<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN"  "JATS-archivearticle1-mathml3.dtd"><article article-type="research-article" dtd-version="1.2" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">67396</article-id><article-id pub-id-type="doi">10.7554/eLife.67396</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Immunology and Inflammation</subject></subj-group></article-categories><title-group><article-title>Intraocular dendritic cells characterize HLA-B27-associated acute anterior uveitis</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes" id="author-225916"><name><surname>Kasper</surname><given-names>Maren</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-2964-8866</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-226657"><name><surname>Heming</surname><given-names>Michael</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-9568-2790</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="other" rid="fund6"/><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-226658"><name><surname>Schafflick</surname><given-names>David</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-226659"><name><surname>Li</surname><given-names>Xiaolin</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-222952"><name><surname>Lautwein</surname><given-names>Tobias</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-226660"><name><surname>Meyer zu Horste</surname><given-names>Melissa</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-226661"><name><surname>Bauer</surname><given-names>Dirk</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-226662"><name><surname>Walscheid</surname><given-names>Karoline</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-90342"><name><surname>Wiendl</surname><given-names>Heinz</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-226663"><name><surname>Loser</surname><given-names>Karin</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" corresp="yes" id="author-226664"><name><surname>Heiligenhaus</surname><given-names>Arnd</given-names></name><email>arnd.heiligenhaus@uveitis-zentrum.de</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-196616"><name><surname>Meyer zu Hörste</surname><given-names>Gerd</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-4341-4719</contrib-id><email>gerd.mzh@uni-muenster.de</email><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund5"/><xref ref-type="fn" rid="con12"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution>Ophtha-Lab, Department of Ophthalmology, and Uveitis Centre at St. Franziskus Hospital</institution><addr-line><named-content content-type="city">Münster</named-content></addr-line><country>Germany</country></aff><aff id="aff2"><label>2</label><institution>Department of Neurology with Institute of Translational Neurology, University Hospital Muenster</institution><addr-line><named-content content-type="city">Muenster</named-content></addr-line><country>Germany</country></aff><aff id="aff3"><label>3</label><institution>Augen-Zentrum-Nordwest Augenpraxis Ahaus</institution><addr-line><named-content content-type="city">Ahaus</named-content></addr-line><country>Germany</country></aff><aff id="aff4"><label>4</label><institution>Department of Ophthalmology, University of Duisburg-Essen</institution><addr-line><named-content content-type="city">Essen</named-content></addr-line><country>Germany</country></aff><aff id="aff5"><label>5</label><institution>Department of Human Medicine, University of Oldenburg</institution><addr-line><named-content content-type="city">Oldenburg</named-content></addr-line><country>Germany</country></aff><aff id="aff6"><label>6</label><institution>University of Duisburg-Essen</institution><addr-line><named-content content-type="city">Essen</named-content></addr-line><country>Germany</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>van de Veerdonk</surname><given-names>Frank L</given-names></name><role>Reviewing Editor</role><aff><institution>Radboudumc Center for Infectious Diseases</institution><country>Netherlands</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Rath</surname><given-names>Satyajit</given-names></name><role>Senior Editor</role><aff><institution>Indian Institute of Science Education and Research (IISER)</institution><country>India</country></aff></contrib></contrib-group><author-notes><fn fn-type="con" id="equal-contrib1"><label>†</label><p>These authors contributed equally to this work</p></fn></author-notes><pub-date date-type="publication" publication-format="electronic"><day>16</day><month>11</month><year>2021</year></pub-date><pub-date pub-type="collection"><year>2021</year></pub-date><volume>10</volume><elocation-id>e67396</elocation-id><history><date date-type="received" iso-8601-date="2021-02-09"><day>09</day><month>02</month><year>2021</year></date><date date-type="accepted" iso-8601-date="2021-09-21"><day>21</day><month>09</month><year>2021</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint at bioRxiv.</event-desc><date date-type="preprint" iso-8601-date="2021-02-18"><day>18</day><month>02</month><year>2021</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2021.02.16.431370"/></event></pub-history><permissions><copyright-statement>© 2021, Kasper et al</copyright-statement><copyright-year>2021</copyright-year><copyright-holder>Kasper et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-67396-v1.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-67396-figures-v1.pdf"/><abstract><p>Uveitis describes a heterogeneous group of inflammatory eye diseases characterized by infiltration of leukocytes into the uveal tissues. Uveitis associated with the HLA haplotype B27 (HLA-B27) is a common subtype of uveitis and a prototypical ocular immune-mediated disease. Local immune mechanisms driving human uveitis are poorly characterized mainly due to the limited available biomaterial and subsequent technical limitations. Here, we provide the first high-resolution characterization of intraocular leukocytes in HLA-B27-positive (n = 4) and -negative (n = 2) anterior uveitis and an infectious endophthalmitis control (n = 1) by combining single-cell RNA-sequencing with flow cytometry and protein analysis. Ocular cell infiltrates consisted primarily of lymphocytes in both subtypes of uveitis and of myeloid cells in infectious endophthalmitis. HLA-B27-positive uveitis exclusively featured a plasmacytoid and classical dendritic cell (cDC) infiltrate. Moreover, cDCs were central in predicted local cell-cell communication. This suggests a unique pattern of ocular leukocyte infiltration in HLA-B27-positive uveitis with relevance to DCs.</p></abstract><abstract abstract-type="executive-summary"><title>eLife digest</title><p>Uveitis is a form of inflammation in the eye. It can occur in response to infection, or when the immune system mistakenly attacks the eye, in what is known as autoimmune uveitis. In approximately 80 percent of cases, the front part of the eye is affected. During an inflammatory episode, the liquid inside the front part of the eye fills with immune cells, but the nature of these cells remains unknown. This is because uveitis is rare, and doctors cannot routinely take samples from inside the eyes of affected individuals to diagnose the disease. This lack of samples makes research into this disease challenging.</p><p>There are two main groups of immune cells that could be responsible for uveitis: myeloid cells and lymphoid cells. Myeloid cells form the first line of immune defense against infection by non-specifically attacking and removing pathogens . Lymphoid cells form the second line of immune defense, attacking specific pathogens. Lymphoid cells also have long-term memory, meaning they can ‘remember’ previous infections and fight them more effectively. Lymphoid cells receive instructions from a type of myeloid cell called a dendritic cell about what to attack. Dendritic cells relay their instructions to lymphoid cells using molecules called human leukocyte antigens (HLA). Autoimmune uveitis affecting the front part of the eye is common in individuals with an HLA type called HLA-B27, suggesting that communication between dendritic and lymphoid cells plays an important role in this type of inflammation.</p><p>To make the most of limited patient samples, Kasper et al. used single cell techniques to examine the immune cells from the fluid inside the eye. Six samples came from people with autoimmune uveitis, and one from a person with an eye infection. The infection sample contained mainly myeloid cells that might attack bacteria responsible for the infection. In contrast, the autoimmune uveitis samples contained mainly lymphoid cells. Of these samples, four were from individuals with the gene that codes for the HLA-B27 molecule. These samples had a unique pattern of immune cells, with more dendritic cells than the samples from individuals that did not have this gene.</p><p>This study included only a small number of individuals, but it shows that analysing single immune cells from the eye is possible in uveitis. This snapshot could help researchers understand the local immune response in the eye, and find an optimal treatment.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>HLA-B27</kwd><kwd>uveitis</kwd><kwd>inflammation</kwd><kwd>dendritic cells</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001659</institution-id><institution>Deutsche Forschungsgemeinschaft</institution></institution-wrap></funding-source><award-id>ME4050/4-1 ME4050/12-1 ME4050/8-1 ME4050/13-1</award-id><principal-award-recipient><name><surname>Meyer zu Hörste</surname><given-names>Gerd</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001659</institution-id><institution>Deutsche Forschungsgemeinschaft</institution></institution-wrap></funding-source><award-id>ME4050/8-1</award-id><principal-award-recipient><name><surname>Meyer zu Hörste</surname><given-names>Gerd</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100002347</institution-id><institution>Bundesministerium für Bildung und Forschung</institution></institution-wrap></funding-source><award-id>01ER1504C</award-id><principal-award-recipient><name><surname>Heiligenhaus</surname><given-names>Arnd</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001659</institution-id><institution>Deutsche Forschungsgemeinschaft</institution></institution-wrap></funding-source><award-id>1877/19-1</award-id><principal-award-recipient><name><surname>Heiligenhaus</surname><given-names>Arnd</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004870</institution-id><institution>Medizinische Fakultät, Westfälische Wilhelms-Universität Münster</institution></institution-wrap></funding-source><award-id>MzH3/020/20</award-id><principal-award-recipient><name><surname>Meyer zu Hörste</surname><given-names>Gerd</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004870</institution-id><institution>Medizinische Fakultät, Westfälische Wilhelms-Universität Münster</institution></institution-wrap></funding-source><award-id>SEED/016/21</award-id><principal-award-recipient><name><surname>Heming</surname><given-names>Michael</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Single-cell transcriptomics of intraocular infiltrate in human HLA-B27-associated active anterior uveitis shows a unique composition and phenotype of leukocytes preferentially affecting dendritic cells.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Uveitis describes a heterogeneous group of inflammatory diseases involving uveal tissues in the intraocular cavity of the eye. Non-infectious uveitis is regarded as an autoimmune disorder and is associated with various immune-mediated systemic diseases. According to the Standardization of Uveitis Nomenclature (SUN) working group, uveitis is classified based on the anatomical location of uveitis as anterior, posterior, intermediate, and panuveitis (<xref ref-type="bibr" rid="bib42">Jabs et al., 2005</xref>). Anterior uveitis (AU) primarily affects the iris and ciliary body and constitutes its most frequent type (approximately 80% of cases) resulting in permanent vision loss through, for example, secondary cataract, glaucoma, or macular edema (<xref ref-type="bibr" rid="bib68">Rothova et al., 1996</xref>; <xref ref-type="bibr" rid="bib74">Thorne et al., 2016</xref>).</p><p>Acute anterior uveitis (AAU) associated with the HLA haplotype B27 (B27+ AAU) is the most common and often severe form of uveitis. Its typical clinical features include acute onset of discomfort, eye redness, tearing, visual impairment, and excessive cellular infiltration in the aqueous humor (AqH; ie, the intraocular liquid of the anterior chamber) that is devoid of immune cells under non-diseased conditions. The prevalence of the HLA-B27 haplotype is approximately 8–10% among Caucasians and 40–70% among AAU patients (<xref ref-type="bibr" rid="bib47">Kopplin et al., 2016</xref>) and thus represents a strong genetic risk factor for AAU (<xref ref-type="bibr" rid="bib11">Brewerton et al., 1973</xref>; <xref ref-type="bibr" rid="bib38">Huhtinen and Karma, 2000</xref>). The HLA-B27 allele also conveys an increased genetic risk for other immune-mediated diseases, including spondyloarthropathies (SpA) and inflammatory bowel disease (IBD). B27+ AAU is thus regarded as a prototypic ocular immune-mediated disease and, accordingly, its treatment is based on corticosteroids (<xref ref-type="bibr" rid="bib46">Khan et al., 2015</xref>; <xref ref-type="bibr" rid="bib66">Rosenbaum, 2015</xref>) and classical and biological disease-modifying anti-rheumatic drugs (<xref ref-type="bibr" rid="bib34">Heiligenhaus et al., 2012</xref>; <xref ref-type="bibr" rid="bib10">Bou et al., 2015</xref>). Notably, although T-cell inhibition (eg, by cyclosporine A) is beneficial in other uveitis entities (<xref ref-type="bibr" rid="bib59">Nussenblatt et al., 1991</xref>), it provides limited efficacy in B27+ AAU (<xref ref-type="bibr" rid="bib30">Gómez-Gómez et al., 2017</xref>), suggesting a yet poorly defined role of innate immune cells in its pathogenesis.</p><p>Immune cells infiltrating the anterior chamber of the eye can be observed clinically, but are difficult to <italic>obtain</italic> for further analyses. In fact, the invasive sampling of AqH is rarely clinically justified. AqH fine-needle aspirates are primarily applied for the verification of, for example, infectious uveitis (<xref ref-type="bibr" rid="bib16">Chronopoulos et al., 2016</xref>) and rarely to unravel the pathogenesis of non-infectious uveitis (<xref ref-type="bibr" rid="bib31">Greiner and Amer, 2008</xref>; <xref ref-type="bibr" rid="bib15">Chen et al., 2015</xref>; <xref ref-type="bibr" rid="bib20">de Groot-Mijnes et al., 2015</xref>; <xref ref-type="bibr" rid="bib90">Zhao et al., 2015</xref>). Our knowledge of AqH-infiltrating leukocytes and underlying mechanisms of uveitis thus remains superficial, despite its frequency and severity.</p><p>In AAU, a role of bacterial triggers has been proposed (<xref ref-type="bibr" rid="bib39">Huhtinen et al., 2002a</xref>; <xref ref-type="bibr" rid="bib40">Huhtinen et al., 2002b</xref>). Therefore, innate immune cells such as monocytes and dendritic cells (DCs) that phagocytose and process foreign antigens are of special interest. In fact, phenotyping of circulating monocytes in patients with immune-mediated uveitis emphasized differences during the disease course (<xref ref-type="bibr" rid="bib54">Liu et al., 2015</xref>; <xref ref-type="bibr" rid="bib81">Walscheid et al., 2016</xref>; <xref ref-type="bibr" rid="bib82">Walscheid et al., 2018</xref>; <xref ref-type="bibr" rid="bib44">Kasper et al., 2018</xref>). The microbiome, intestinal barrier dysfunction, and immune response have also been suggested to contribute to the pathogenesis of AAU (<xref ref-type="bibr" rid="bib67">Rosenbaum and Asquith, 2018</xref>). Soluble mediators (<xref ref-type="bibr" rid="bib6">Bauer et al., 2020</xref>; <xref ref-type="bibr" rid="bib1">Abu El-Asrar et al., 2020</xref>; <xref ref-type="bibr" rid="bib5">Bauer et al., 2018</xref>; <xref ref-type="bibr" rid="bib8">Bonacini et al., 2020</xref>) and infiltrating leukocytes have been analyzed (<xref ref-type="bibr" rid="bib22">Denniston et al., 2012</xref><ext-link ext-link-type="uri" xlink:href="https://sciwheel.com/work/citation?ids=9388457&amp;pre=&amp;suf=&amp;sa=0">)</ext-link> previously in the AqH of uveitis patients, but access to samples and technical challenges remain the main bottlenecks toward better understanding the pathomechanisms in uveitis.</p><p>Single-cell RNA-sequencing (scRNA-seq) studies have provided unprecedented high-resolution insights into immune mechanisms in various tissues (<xref ref-type="bibr" rid="bib35">Heming et al., 2021</xref>; <xref ref-type="bibr" rid="bib86">Wolbert et al., 2020</xref>). Therefore, we here combined scRNA-seq with flow cytometry and protein analysis of soluble cytokines and thereby provide the first partially unbiased characterization of leukocytes in the AqH from patients with B27+ AAU compared to patients with HLA-B27-negative AU (B27-AU) and acute infectious endophthalmitis. We found that lymphocytes predominate in the intraocular infiltrate in B27+ AAU and specifically showed an elevated frequency of plasmacytoid DCs (pDCs) and classical DCs (cDCs). In B27+ AAU, DCs featured the most predicted intercellular interactions and increased expression of AAU- and SPA-related genome-wide association study (GWAS) risk genes that distinguished this uveitis from active B27-AU. This suggests a specific involvement of DCs in B27+ AAU, and subtypes of AU thus exhibit specific patterns of local leukocyte responses.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Single-cell analysis of AqH requires optimized sample processing and recruitment</title><p>We here aimed for an unbiased characterization of leukocytes in the AqH in AU flares. We screened 4980 total patients with any intraocular inflammation seen at our uveitis center. We included 11 patients with current onset of uveitis flare (n = 8) or endophthalmitis (n = 3) into this study, being untreated with topical corticosteroids for this flare (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1a</xref>), corresponding to a recruitment rate of approximately 0.18%. In 10 of the AqH samples, cytokine analysis was performed. Cellular infiltrates were analyzed via scRNA-Seq in AqH samples of four patients with active B27+ AAU, two patients with active B27-AU, and one patient with active bacterial endophthalmitis (<italic>Streptococcus pneumoniae</italic>); five of those samples were analyzed in parallel via flow cytometry (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1a</xref>). Deep characterization of AqH-infiltrating leukocytes is thus feasible.</p><p>The endophthalmitis patients were significantly older than B27+ AAU patients (analysis of variance (ANOVA), p = 0.0157; <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1a</xref>). There were four females in the B27-AU cohort, and three males and one female in the B27+ AAU cohort. All B27+ AAU patients had associated SpA, and two of them received adalimumab therapy. Both uveitis groups did not differ significantly regarding age (ANOVA, p = 0.566), Antinuclear antibodies (ANA) status, frequency of systemic anti-inflammatory treatment, topical medication, previous ocular surgery, or time since uveitis onset.</p></sec><sec id="s2-2"><title>Single-cell transcriptomics reconstructs key leukocyte lineages in aqueous humor</title><p>We then performed scRNA-seq of ocular infiltrating cells from fresh AqH fine-needle aspirates (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1a</xref>). We defined 5000 input cells as our maximum intended input per sample and used excess cells beyond that number for flow cytometry analysis. Thereby, we obtained transcriptional information of 13,550 total individual cells and 1936 average cells (± 1411 SD) per patient with 830 average genes (± 402 SD) detected per cell (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1b</xref>). This is in accordance with the expected cell recovery rate of 50% of the scRNA-seq technique we employed (<xref ref-type="bibr" rid="bib91">Zheng et al., 2017</xref>). After quality control, we clustered the single-cell (sc) transcriptomes of all patients combined and identified 13 individual cell clusters (<xref ref-type="fig" rid="fig1">Figure 1A and B</xref>). We manually annotated these clusters based on the expression of marker genes (<xref ref-type="fig" rid="fig1">Figure 1C</xref>, <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>, <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1c</xref>). As previously shown in AqH aspirates of human uveitis patients (<xref ref-type="bibr" rid="bib22">Denniston et al., 2012</xref>), only hematopoietic cell clusters were identified. Clusters were broadly classified into cells of myeloid (40%; cDCa, cDCb, pDC, mature DC (matDC), granulo, myeloid) and of lymphoid origin (60%; natural killer (NK), γδ T cells (gdTC), CD8, regulatory T (Treg), CD4, naive B cells (Bc), plasma). Myeloid clusters separated into cDC clusters tentatively named cDCa (<italic>ITGAX, CLEC7A</italic>) and cDCb (<italic>CLEC10A, MRC1</italic>), pDC (<italic>IL3RA/</italic>CD123<italic>, CLEC4C/</italic>CD303) and matDC (<italic>TMEM176B, IDO1, FSCN1, LAMP3, CD83</italic>), granulocytes (granulo; S100A12/ <italic>S100 A8 high, CCL2 low</italic>), and myeloid cells with unclear assignment (myeloid; S100A12/<italic>S100 A8 low, CCL2 high</italic>) (<xref ref-type="fig" rid="fig1">Figure 1C</xref>). The marker genes expressed by the cDC sub-clusters did not fully overlap with previously described cDC type 1/2 markers used to identify DC subsets from cerebrospinal fluid (DC1: <italic>CLEC9A, XCR1, BATF3</italic>; DC2: <italic>CD1C, FCER1A, CLEC10A</italic>) (<xref ref-type="bibr" rid="bib35">Heming et al., 2021</xref>) or peripheral blood (DC1: <italic>CLEC9A, C1ORF54, HLA-DPA1, CADM1, CAMK2D</italic>; DC2: CD1C, FCER1A, CLEC10A, ADAM8) (<xref ref-type="bibr" rid="bib78">Villani et al., 2017</xref>). We therefore intentionally named these clusters cDCa/b to prevent ambiguity.</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Single-cell transcriptomics reconstructs leukocyte subsets infiltrating the eye.</title><p>(<bold>A</bold>) Uniform manifold approximation and projection (UMAP) projection of seven pooled samples (control n = 1; B27-AU n = 2; B27+ AAU n = 4). The single-cell (sc) transcriptomes were manually annotated to cell types based on marker gene expression and distinguished in 13 cell clusters (color-coded; each dot represents one cell). (<bold>B</bold>) The mean proportion of cells (%) in each cluster per group is depicted in a stacked bar plot. (<bold>C</bold>) Dot plot of selected marker genes grouped by cluster. The average gene expression level is color-coded, and the circle size represents the percentage of cells expressing the gene. Threshold was set to a minimum of 10% of cells in the cluster expressing the gene. DC: dendritic cell, pDC: plasmacytoid DC, matDC: mature DC; granulo: granulocytes, NK cells: natural killer cells, gdTC: γδ T cells, Treg cells: regulatory T cells, Bc: B cells.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-67396-fig1-v1.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Feature plots of lineage marker genes.</title><p>Expression of lineage markers <italic>ITGAX, AXL, CLEC10A, MRC1, CLEC4C, IL3RA, CD83, LAMP3, CCL2, S100A8, CD33, S100A12, CD4, CD3G, CD8A, TRBC2, FOXP3, IL2RA, GNLY, IL7R, TRDC, NKG7, MS4A1,</italic> and <italic>IGHG1</italic> is shown as feature plots. Each dot represents one cell.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-67396-fig1-figsupp1-v1.tif"/></fig></fig-group><p>Lymphoid clusters were classified as CD4+ T cells (CD4; <italic>IL7R, CD3G</italic>), CD8+ T cells (CD8; <italic>CD8A, CD3G</italic>), gdTC (<italic>NKG7, TRDC</italic>), Treg cells (<italic>IL2RA, FOXP3</italic>), NK cells (<italic>GNLY, NKG7</italic>), naive Bc (<italic>MS4A1, CD19, IGHD</italic>), and plasma cells (plasma; <italic>IGHG1, CD38, SDC1/</italic>CD138) (<xref ref-type="fig" rid="fig1">Figure 1C</xref>). We thus identified all major leukocyte lineages in AqH fine-needle aspirates (<xref ref-type="fig" rid="fig1">Figure 1B</xref>, <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1d</xref>).</p></sec><sec id="s2-3"><title>Diverse uveitis entities exhibit a unique intraocular leukocyte composition</title><p>We next sought to understand how intraocular inflammation differed between uveitis entities. First, we assessed the endophthalmitis control patient and found almost exclusively myeloid lineage clusters with predominating granulocytes in accordance with an acute anti-bacterial response (<xref ref-type="fig" rid="fig2">Figure 2B</xref>; <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>; <xref ref-type="bibr" rid="bib25">Engstrom et al., 1991</xref>).</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>A unique intraocular leukocyte pattern characterizes individual uveitis causes.</title><p>(<bold>A</bold>) UMAP projection of pooled B27-AU (n = 2) versus pooled B27+ AAU (n = 4) samples. The single-cell (sc) transcriptomes were manually annotated to cell types based on marker gene expression and distinguished in 13 cell clusters (color-coded; each dot represents one cell). (<bold>B</bold>) The proportion of cells (%) in each cluster is depicted in a stacked bar plot for individual samples. (<bold>C</bold>) Dot plot of cluster abundance of B27-AU versus B27+ AAU. The x axis represents the decadic logarithm of fold change of proportional cluster size. (<bold>D</bold>) Box plots of proportion of cells (%) of cDCa and pDC from B27-AU and B27+ AAU. The boxes show the median, and the lower and upper quartile. Whiskers include 1.5 times the interquartile range of the box. The overlaid dots represent individual observations. (<bold>E</bold>) Leukocytes of aqueous humor (AqH) samples were analyzed according to their frequency (%) of granulocytes, monocytes/macrophages/DCs, CD4+ and CD8+ T cells, and NK cells. The proportion of each cell population identified via flow cytometry is depicted in a stacked bar plot. DC: dendritic cell, pDC: plasmacytoid DC, matDC: mature DC; granulo: granulocytes, NK cells: natural killer cells, gdTC: γδ T cells, Treg cells: regulatory T cells, Bc: B cells, mono: monocyte, macro: macrophage.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-67396-fig2-v1.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Individualized scRNA-seq results of anterior chamber-derived leukocytes.</title><p>UMAP projection as in <xref ref-type="fig" rid="fig2">Figure 2A</xref> of only the endophthalmitis control patient. The single-cell (sc) transcriptomes were manually annotated to cell types based on marker gene expression and distinguished in 13 cell clusters (color-coded; each dot represents one cell).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-67396-fig2-figsupp1-v1.tif"/></fig><fig id="fig2s2" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 2.</label><caption><title>Flow cytometric analysis of aqueous humor samples.</title><p>(<bold>A</bold>) Leukocytes in side scatter (SSC)/forward scatter (FSC) scatter were identified, doublets were excluded, and leukocytes were gated on CD3-CD11b+ myeloid cells, CD3+ CD11b- T cells, and CD3-CD11b- cells. Myeloid cells were further classified into CD11c+ HLA-DR- granulocytes and CD11c+ HLA-DR+ monocytes/macrophages/dendritic cells (DCs). T cells were further subdivided into CD4+- and CD8+-expressing cells. CD3-CD11b- cells were analyzed according to their frequency of CD56+ natural killer (NK) cells. Representative analysis is shown. (<bold>B</bold>) Correlation plot (Spearman’s correlation coefficient) between flow proportions (columns) and single-cell RNA-sequencing (scRNA-seq) (rows) proportions is shown as a heatmap, with high correlation coefficients shown in red.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-67396-fig2-figsupp2-v1.tif"/></fig></fig-group><p>In contrast, the cellular infiltrates in B27-AU and B27+ AAU patients’ AqH were of more lymphoid origin, reflecting their autoimmune etiology (<xref ref-type="fig" rid="fig2">Figure 2A and B</xref>). When systematically comparing B27+ AAU vs B27-AU samples, inter-patient variability was high (<xref ref-type="fig" rid="fig2">Figure 2A and B</xref>), but several populations still substantially differed between uveitis subtypes (<xref ref-type="fig" rid="fig2">Figure 2C</xref>, <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1d</xref>). While the CD8 and naive Bc clusters were reduced, the pDC and cDCa clusters were more abundant in B27+ AAU patients (<xref ref-type="fig" rid="fig2">Figure 2C and D</xref>), overall indicating an influx or expansion of DC in this uveitis entity.</p><p>Next, we sought to confirm our findings using flow cytometry (<xref ref-type="fig" rid="fig2">Figure 2E</xref>; <xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2</xref>). The expression of canonical lineage markers differs between mRNA and protein quantification (<xref ref-type="bibr" rid="bib61">Peterson et al., 2017</xref>), and we therefore used widely applicable pan-lineages in flow cytometry. AqH-derived cells of some of the patients (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1a</xref>) were analyzed to distinguish granulocytes (CD3<sup>-</sup>CD11b<sup>+</sup>HLA-DR<sup>-</sup>), monocytes/macrophages/DCs (CD3<sup>-</sup>CD11b<sup>+</sup>HLA-DR<sup>+</sup>), CD4<sup>+</sup> and CD8<sup>+</sup> T cells (CD3<sup>+</sup>CD11b<sup>-</sup>), and NK cells (CD3<sup>-</sup>CD11b<sup>-</sup>CD56<sup>+</sup>). This confirmed the mainly myeloid infiltrate in the endophthalmitis patient (<xref ref-type="fig" rid="fig2">Figure 2E</xref>). B27-AU patients showed an infiltrate dominated by T cells, low NK cells, and low cells of myeloid origin. In B27+ AAU patients, myeloid cells were more abundant than in B27-AU (<xref ref-type="fig" rid="fig2">Figure 2E</xref>). Also, the abundance of broad cell classes quantified by scRNA-seq and flow cytometry showed a positive correlation (<xref ref-type="fig" rid="fig2">Figure 2E</xref>, <xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2B</xref>). The higher frequency of granulocytes detected in flow cytometry than in the scRNA-seq might be due to the higher fragility of these cells during processing for scRNA-seq (<xref ref-type="bibr" rid="bib92">Zilionis et al., 2019</xref>). Overall, subtypes of uveitis were thus characterized by a unique pattern of local inflammatory cells.</p></sec><sec id="s2-4"><title>Specific transcriptional phenotype of intraocular leukocytes in subtypes of uveitis</title><p>Next, we sought to understand how local leukocytes differ transcriptionally between uveitis entities. To analytically account for low total cell numbers, we merged clusters into five broad cell type of ‘meta-clusters’ for differential expression analysis (<xref ref-type="fig" rid="fig3">Figure 3A</xref>, <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1e</xref>): helper T cells (<italic>help</italic>; Treg, CD4), cytotoxic cells (<italic>toxic</italic>; CD8, NK, gdTC), merged DCs (<italic>mergeDC</italic>; matDC, pDC, cDCa, cDCb), other myeloid cells (<italic>myeloidLin</italic>; myeloid, granulo), and B-cell lineage (<italic>BcLin</italic>: naive Bc, plasma). We then tested for differentially expressed (DE) genes between B27+ AAU and B27-AU. Across all clusters, multiple major histocompatibility complex (MHC) class I and class II related genes (<italic>HLA-A</italic>, <italic>HLA-DPA1</italic>, <italic>HLA-DRA</italic>, <italic>HLA-DRB1, B2M</italic>) were expressed at lower levels in B27+ AAU samples (<xref ref-type="fig" rid="fig3">Figure 3B–F</xref>). Furthermore, in B27+ AAU, the <italic>help</italic> and <italic>BcLin</italic> meta-clusters downregulated one cytokine receptor (<italic>CXCR4</italic>). The <italic>toxic</italic> meta-cluster downregulated signs of cytotoxicity (<italic>GZMK, GZMH, LTA</italic>). The <italic>BcLin</italic> meta-cluster featured an increase of macrophage-inhibitory factor (<italic>MIF</italic>), known to inhibit NK cell activity (<xref ref-type="bibr" rid="bib2">Apte et al., 1998</xref>). The <italic>myeloid</italic> meta-cluster reduced expression of several interferon (IFN)-regulated genes (<italic>IFITM</italic> genes; <xref ref-type="fig" rid="fig3">Figure 3B–F</xref>).</p><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Intraocular leukocytes express a subtype-specific transcriptional phenotype.</title><p>(<bold>A</bold>) UMAP projection of pooled B27-AU (n = 2) versus pooled B27+ AAU (n = 4) samples. The single-cell (sc) transcriptomes were manually annotated to cell types based on marker gene expression and distinguished in five meta-clusters (color-coded; each dot represents one cell). Differentially expressed (DE) genes of B27-AU vs B27+ AAU of each meta-cluster (<bold>B</bold>) <italic>mergeDC</italic> (matDC, pDC, DCa, cDCb), (<bold>C</bold>) <italic>myeloidLin</italic> (myeloid, granulo), (<bold>D</bold>) <italic>help</italic> (Treg, CD4), (<bold>E</bold>) <italic>toxic</italic> (CD8, NK, gdTC), (<bold>F</bold>) and <italic>BcLin</italic> (naive Bc, plasma) are depicted as volcano plots. The threshold for average natural logarithmic fold change (avg logFC) was set to 0.5 and for adjusted p-value, to 0.001. Selected genes are labeled. (<bold>G</bold>) Heatmap showing differences in average gene expression (B27+ AAU minus B27-AU) of genome-wide association study (GWAS) risk genes (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1g</xref>). Data were scaled column wise. Columns were clustered using euclidean distance measure and complete linkage. Yellow color indicates a higher expression in B27+ AAU samples, and blue color indicates a higher expression in B27-AU samples. Risk genes for anterior uveitis and for spondyloarthropathies (SpA) are labeled in red and black, respectively. DC: dendritic cell, pDC: plasmacytoid DC, matDC: mature DC; granulo: granulocytes, NK cells: natural killer cells, gdTC: γδ T cells, Treg cells: regulatory T cells, Bc: B cells, <italic>BcLin</italic>, B-cell lineage.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-67396-fig3-v1.tif"/></fig><p>Elevated <italic>CTNN1</italic> expression in mergeDC (<xref ref-type="fig" rid="fig3">Figure 3B</xref>) pointed to an involvement of the WNT/catenin pathway as previously described for SpA (<xref ref-type="bibr" rid="bib87">Xie et al., 2016</xref>). Increased expression of <italic>Lyz</italic> and its cognate antisense <italic>AC020656.1,</italic> and <italic>CALR</italic> (<xref ref-type="bibr" rid="bib55">Liu et al., 2016</xref>) and its antisense <italic>AC092069.1,</italic> within the mergeDC cluster suggested an activation of myeloid cells and simultaneously local counter regulating mechanisms. Elevated expression of <italic>B4GALT1</italic> in mergeDC, in detail cDCa and cDCb (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1f</xref>), potentially reflected the migratory capacity of DC (<xref ref-type="bibr" rid="bib43">Johnson and Shur, 1999</xref>). Notably, the mergeDC, help, and toxic meta-clusters all upregulated <italic>C1ORF56</italic>, an oncogene previously found induced in activated lymphocytes in IBD (<xref ref-type="bibr" rid="bib76">Uniken Venema et al., 2019</xref>) and splenic NK cells (<xref ref-type="bibr" rid="bib18">Crinier et al., 2018</xref>).</p><p>We also found elevated expression of prefoldin 5 (<italic>PFDN5</italic>) in <italic>myeloid</italic>, <italic>toxic,</italic> and <italic>help</italic> clusters (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1e</xref>), which was recently described as a specific marker for B27+ AAU associated with SpA (<xref ref-type="bibr" rid="bib49">Kwon et al., 2019</xref>). Furthermore, as previously shown in joint biopsies of SpA patients (<xref ref-type="bibr" rid="bib14">Carlberg et al., 2019</xref>; <xref ref-type="bibr" rid="bib51">Lam et al., 2019</xref>) and in association with autoinflammatory diseases (<xref ref-type="bibr" rid="bib14">Carlberg et al., 2019</xref>; <xref ref-type="bibr" rid="bib51">Lam et al., 2019</xref>), elevated expression of <italic>CDC42</italic> was detected in mergeDC, myeloid, and help clusters and of <italic>CDC42SE1</italic> in mergeDC, myeloid, help, and toxic clusters (<xref ref-type="fig" rid="fig3">Figure 3B–E</xref>).</p><p>The risk for developing HLA-B27-associated autoimmune diseases is partially determined by variants in non-HLA genetic loci (<xref ref-type="bibr" rid="bib65">Robinson et al., 2015</xref>; <xref ref-type="bibr" rid="bib53">Lin et al., 2011</xref>; <xref ref-type="bibr" rid="bib3">Australo-Anglo-American Spondyloarthritis Consortium (TASC) et al., 2010</xref>; <xref ref-type="bibr" rid="bib52">Li et al., 2019</xref>; <xref ref-type="bibr" rid="bib26">Evans et al., 2011</xref>; <xref ref-type="bibr" rid="bib41">International Genetics of Ankylosing Spondylitis Consortium (IGAS) et al., 2013</xref>; <xref ref-type="bibr" rid="bib75">Trochet et al., 2019</xref>; <xref ref-type="bibr" rid="bib24">Ellinghaus et al., 2016</xref>; <xref ref-type="bibr" rid="bib37">Huang et al., 2020</xref>). We therefore interlinked our transcriptional data with existing genetic information, by testing which ‘meta-clusters’ differentially expressed AAU/SpA risk genes between B27+ AAU and B27-AU (<xref ref-type="fig" rid="fig3">Figure 3G</xref>, <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1g</xref>). Both uveitis-related and SpA-related risk genes were included in the analysis because all B27+ AAU patients had systemic SpA (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>). Many SpA-related risk genes were highly expressed in the <italic>BcLin</italic> cluster (eg, <italic>CLEC16A, IFNLR1</italic>), and in the mergeDC cluster (eg, <italic>IFNGR2, AHR</italic>) in B27+ AAU (<xref ref-type="fig" rid="fig3">Figure 3G</xref>, <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1g</xref>). Compared to B27-AU, expression of genes involved in the detection of pathogens (eg, <italic>CARD9, TLR4</italic>) showed lower expression in the mergeDC cluster in B27+ AAU. Notably, most AU-related risk genes were preferentially expressed in the B27+ AAU mergeDC cluster (eg, <italic>EYS, HLA-DRB5</italic>, <italic>ERAP1</italic>, and <italic>IL18R1</italic>). This indicates the relevance of DC in B27+ AAU.</p></sec><sec id="s2-5"><title>Subtype-specific local leukocyte communication in uveitis</title><p>We also attempted to understand how uveitis controlled the local inter-cellular signaling circuitry. We therefore used a computational tool (CellPhoneDB; <xref ref-type="bibr" rid="bib23">Efremova et al., 2020</xref>) to predict cell-cell interactions between human leukocytes in uveitis from scRNA-seq data. The pDC and plasma clusters had to be excluded because of their small size in B27-AU. In the resulting analysis, the granulo and myeloid clusters had the highest number of predicted interactions (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>). In both uveitis groups, most interactions were between myeloid, granulo, gdTC, and multiple DC clusters. Myeloid lineage clusters thus express the highest capacity for cell-cell interaction.</p><p>Next, we tested for differences of predicted interactions between both subtypes of uveitis. We calculated the number of predicted interactions in B27+ AAU minus that in B27-AU (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). B27-AU displayed many interactions between T/NK clusters with myeloid, matDC, and cDCb clusters (<xref ref-type="fig" rid="fig4">Figure 4A</xref>, <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A</xref>). In contrast, the cDCa cluster showed widespread interactions in B27+ AAU (<xref ref-type="fig" rid="fig4">Figure 4A</xref>, <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1B</xref>.). This suggests that preferential interactions differ between uveitis entities and that the cDCa cluster might be involved in intraocular inflammation in B27+ AAU.</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Altered local inter-cellular signaling in uveitis.</title><p>(<bold>A</bold>) The total count of receptor-ligand interactions between cell clusters of B27-AU and B27+ AAU single-cell (sc) transcriptomes was obtained with CellPhoneDBv2.0 (see <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref> for separate analyses). The heatmap shows the differences between B27+ AAU and B27-AU (amount of predicted interactions of all cell types, excluding plasma and plasmacytoid DC (pDC) due to few cells (&lt;10) of B27+ AAU minus those of B27-AU). (<bold>B</bold>) Overview of all ligand–receptor interactions of the cDCa cluster with at least one significant interaction. Circle size indicates the p-values. The means of the average expression level of interacting molecule 1 in cluster 1 and interacting molecule 2 in cluster 2 are color-coded. (<bold>C</bold>) Heatmap showing aqueous humor (AqH) cytokine level of B27-AU (n = 3) and B27+ AAU (n = 4) patients (see <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1h</xref> showing single values). Data were scaled column wise. Columns were clustered using euclidean distance measure and complete linkage. (<bold>D</bold>) Box plots of interleukin (IL)-2, IL-6, interferon (IFN)-γ, IL-18, IL-22, IL-1β, IL-5, IL-17A, and IL-1 receptor antagonist (IL-1RA) (pg/ml) in the AqH of patients with B27-AU and B27+ AAU. Dots represent individual data. Mann-Whitney U-test (*p&lt;0.05).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-67396-fig4-v1.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>Detailed results of the interactome prediction analysis.</title><p>Predicted receptor-ligand interactions between cell clusters in (<bold>A</bold>) B27-AU and (<bold>B</bold>) B27+ AAU were obtained with CellPhoneDBv2.0. The legend represents the amount of interactions.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-67396-fig4-figsupp1-v1.tif"/></fig><fig id="fig4s2" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 2.</label><caption><title>Cytokine expression in meta-cluster and cytokine serum level.</title><p>(<bold>A</bold>) Heatmap showing gene expression of cytokines that were used for luminex analysis within each ´meta-cluster´. Data were scaled column wise. Columns were clustered using euclidean distance measure and complete linkage. (<bold>B</bold>) Heatmap showing the serum cytokine level of B27-AU (n = 5) and B27+ AAU (n = 6) patients (see <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1i</xref> showing single values). Data were scaled row wise. Columns were clustered hierarchically using euclidean distance measure and complete linkage. (<bold>C</bold>) Box plots of interferon (IFN)-γ and interleukin-1 receptor antagonist (IL-1RA) (pg/ml) in the sera of patients with B27-AU and B27+ AAU. Dots represent individual data. Mann-Whitney U-test (*p&lt;0.05).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-67396-fig4-figsupp2-v1.tif"/></fig></fig-group><p>Notably, when focusing on individual interactions of the cDCa cluster (<xref ref-type="fig" rid="fig4">Figure 4B</xref>), MHC class II-related transcripts (eg, <italic>CD74, HLA-E</italic>) were predicted to interact with surface molecules such as <italic>MIF</italic> or <italic>KLRC1</italic> with immunomodulatory capacity and known association to autoimmunity (<xref ref-type="bibr" rid="bib28">Figueiredo et al., 2018</xref>; <xref ref-type="bibr" rid="bib9">Borrego et al., 1998</xref>). The predicted interaction of cDCa with pDC clusters in B27+ AAU samples also included the <italic>LAIR-LILRB4</italic> and <italic>AXL-GAS6</italic> interaction pairs (<xref ref-type="fig" rid="fig4">Figure 4B</xref>) that exert immunosuppressive phagocytosing functions (<xref ref-type="bibr" rid="bib70">Scutera et al., 2009</xref>; <xref ref-type="bibr" rid="bib12">Brown et al., 2009</xref>). Overall, our findings indicate subtype-specific local inter-cellular leukocyte signaling and indicate that DC forms a central signaling node in uveitis.</p></sec><sec id="s2-6"><title>Increased level of pro-inflammatory cytokines in AAU patients</title><p>Next, we sought to characterize the intraocular immune response through the analysis of soluble mediators. We therefore quantified a predefined set of cytokines in the AqH of these patient groups (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1h</xref>). Several cytokines were below detection limits, and the most notable feature of all these samples was a pronounced presence of interleukin (IL)-6 and IL-1 receptor antagonist (IL-1RA). High levels of immunosuppressive IL1-RA in AqH of uveitis/endophthalmitis patients have also been shown in B27+ AAU patients (<xref ref-type="bibr" rid="bib90">Zhao et al., 2015</xref>; <xref ref-type="bibr" rid="bib21">de Vos et al., 1994</xref>; <xref ref-type="bibr" rid="bib62">Planck et al., 2012</xref>) and may reflect the immune-privileged microenvironment in the anterior chamber (<xref ref-type="bibr" rid="bib90">Zhao et al., 2015</xref>; <xref ref-type="bibr" rid="bib21">de Vos et al., 1994</xref>; <xref ref-type="bibr" rid="bib62">Planck et al., 2012</xref>; <xref ref-type="bibr" rid="bib19">Dana et al., 1998</xref>). The cytokine milieu in endophthalmitis was characterized by innate-related IL-6<bold>,</bold> tumor necrosis factor (TNF)-α, and IL-1β (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1h</xref>), which are involved in ocular barrier breakdown and leukocyte recruitment into ocular tissue (<xref ref-type="bibr" rid="bib33">Hao et al., 2016</xref>; <xref ref-type="bibr" rid="bib27">Feys et al., 1994</xref>; <xref ref-type="bibr" rid="bib29">Giese et al., 1998</xref>).</p><p>Across uveitis entities, the interindividual heterogeneity of cytokine patterns was high (<xref ref-type="fig" rid="fig4">Figure 4C and D</xref>). When comparing uveitis entities, the B27+ AAU group showed significantly increased levels of IL-2, IL-6, IL-18, IL-22, IL-1β, and interferon (IFN)-γ (<xref ref-type="fig" rid="fig4">Figure 4C and D</xref>).</p><p>When comparing this with the scRNA-seq dataset, cytokine expression was identified across all ‘meta-clusters’ (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2A</xref>), but not all cytokines were detected (eg, <italic>IL31, IL5, IL9, IL21,</italic> and <italic>IFNA1</italic>). Single-cell transcriptomics is generally prone to false negatives (<xref ref-type="bibr" rid="bib77">Vieth et al., 2019</xref>), and stromal cells and resident immune cells in the iris can also express proinflammatory cytokines (<xref ref-type="bibr" rid="bib58">Miyamoto et al., 1999</xref>), which may explain the discrepancy between techniques.</p><p>We additionally performed analysis of B27+ AAU and B27-AU serum samples, recruited during the active uveitis disease stage in the context of another project (<xref ref-type="bibr" rid="bib44">Kasper et al., 2018</xref>; <xref ref-type="bibr" rid="bib45">Kasper, 2020</xref>). There, we found significantly elevated IL-1RA and IFN-γ levels in the serum of B27+ AAU as compared to B27-AU patients (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2B,C</xref>; <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1i</xref>). This indicates a potential role of IFN-γ in both intraocular and systemic immune response during uveitis activity in patients with SpA.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Here, we provide the first high-resolution characterization of rare and difficult-to-obtain intraocular leukocytes in AU. By making scRNA-seq per se applicable to the AqH, we found that intraocular leukocytes are transcriptionally and compositionally different not only from blood (<xref ref-type="bibr" rid="bib91">Zheng et al., 2017</xref>) but also from other tissues affected by autoimmune diseases such as synovial fluid in rheumatoid arthritis (<xref ref-type="bibr" rid="bib71">Stephenson et al., 2018</xref>) or cerebrospinal fluid in multiple sclerosis (<xref ref-type="bibr" rid="bib69">Schafflick et al., 2020</xref>). By comparing HLA-B27-positive versus -negative AU, we identified a unique composition of intraocular leukocytes in B27+ AAU. Notably, B27+ AAU showed an elevated frequency of pDc and cDC. In B27+ AAU, cDC had the highest amounts of predicted intercellular interactions and increased expression of AAU- and SpA-related GWAS risk genes that distinguished this uveitis from active B27-AU. This indicates the relevance of cDC in promoting intraocular inflammation.</p><p>Our findings allow diverse speculations on the pathogenesis of HLA-B27-associated AAU. We found T cells more activated in B27-AU than in B27+ AAU in accordance with the poor response of B27+ AAU to T-cell inhibition (<xref ref-type="bibr" rid="bib30">Gómez-Gómez et al., 2017</xref>). The cell-to-cell network analysis revealed an involvement of <italic>TNFSF13B</italic> (<italic>BAFF</italic>), connecting naive Bc and plasma cells to cDCa. A previous study has shown enhanced levels of the B-cell factors BAFF and APRIL in AqH of AAU patients during inactive uveitis, pointing to a role of intraocular B cells in AAU (<xref ref-type="bibr" rid="bib85">Wildschütz et al., 2019</xref>). Notably, naive Bc expressing CLEC16A (<xref ref-type="bibr" rid="bib64">Rijvers et al., 2020</xref>), and plasma cells, expressing several SpA risk genes, were preferentially enriched in B27+ AAU. Also, plasma cells and the intraocular plasma cluster do not express <italic>MS4A1/</italic>CD20 and, accordingly, SpA patients (with or without AAU) mostly do not benefit from treatment with the anti-CD20 antibody rituximab (<xref ref-type="bibr" rid="bib84">Wendling et al., 2012</xref>).</p><p>Several lines of evidence—including our study—indicate that SpA-associated B27+ AAU may be driven by innate immune cells triggered through innate pattern recognition of endogenous or exogenous pathogens. One study identified CD14+ monocytes/macrophages and a separate CD14−/low BDCA-1+ (CD1c) myeloid DC population in AqH of patients with AU (<xref ref-type="bibr" rid="bib22">Denniston et al., 2012</xref>). This lends support to a central hub function of DC.</p><p>DCs—as professional antigen-presenting cells—orchestrate the interplay between innate and adaptive immunity. The classification of DCs is complex. Traditionally, three DC subsets were defined as classical (or myeloid) DC type 1 (cDC1) or type 2 (cDC2), and pDC (<xref ref-type="bibr" rid="bib57">Merad et al., 2013</xref>). Additional subdivisions and the definition of monocyte-derived DCs further complexify the field (eg, <xref ref-type="bibr" rid="bib78">Villani et al., 2017</xref>; <xref ref-type="bibr" rid="bib88">Yin et al., 2017</xref>; <xref ref-type="bibr" rid="bib17">Collin and Bigley, 2018</xref>). We identified four intraocular DC clusters in two different uveitis entities. As the marker genes identified in our study partially differed from cDC1/cDC2 in other tissues (<xref ref-type="bibr" rid="bib35">Heming et al., 2021</xref>; <xref ref-type="bibr" rid="bib78">Villani et al., 2017</xref>), we used a distinct annotation as cDCa/b. We also identified a novel DC cluster that expressed genes related to activation and maturity (<italic>FSCN1, CD83, LAMP3</italic>), and was therefore designated as matDC cluster. LAMP3 was previously shown to mediate migration from tumor to regional lymph nodes and exert regulatory capacity on other cells (<xref ref-type="bibr" rid="bib89">Zhang et al., 2019</xref>). Furthermore, we identified DC5 cells, characterized by their high expression of <italic>AXL</italic> and <italic>SIGLEC6</italic> (<xref ref-type="bibr" rid="bib78">Villani et al., 2017</xref>)<italic>,</italic> within the cDCa, matDC, and pDC cluster. Expression of immune regulatory <italic>MIF</italic> and <italic>AXL</italic> in cells of cDCa cluster and their multiple predicted interactions with other infiltrating immune cells point to an immune regulatory and/or phagocytosing role of these cells during AAU.</p><p>Pathogens are one potential trigger of autoimmune uveitis in mice and intestinal and joint inflammation in rats overexpressing human HLA-B27 antigen (<xref ref-type="bibr" rid="bib73">Taurog et al., 1994</xref>). Anti-<italic>Saccharomyces cerevisiae</italic> antibodies are elevated in patients with SpA and point to an involvement of CARD9 or NOD2 (<xref ref-type="bibr" rid="bib56">Maillet et al., 2016</xref>). Transcriptional candidate risk genes related to innate immunity (eg, <italic>CARD9</italic>, <italic>NOD2</italic>, <italic>TLR4</italic>) were expressed at a lower level in the DC populations of B27+ AAU patients, questioning the role of bacterial and fungal pathogens in intraocular immune response.</p><p>In scRNA-seq, the alarmins S100A8/S100A9 are assigned mainly as marker genes for granulocytes and other phagocytes (<xref ref-type="bibr" rid="bib91">Zheng et al., 2017</xref>). Furthermore, elevated S100A8/A9 expression points to an involvement of toll-like receptor (TLR) signaling and activation of innate immune cells. Thus, elevated S100A8/A9 and S100A12 levels serve as activity biomarkers of diverse autoimmune diseases (<xref ref-type="bibr" rid="bib63">Pruenster et al., 2016</xref>; <xref ref-type="bibr" rid="bib4">Baillet et al., 2010</xref>; <xref ref-type="bibr" rid="bib79">Vogl et al., 2018</xref>; <xref ref-type="bibr" rid="bib80">Walscheid et al., 2015</xref>). In particular, S100A8/A9 serum levels are increased constitutively in patients with HLA-B27-associated uveitis (<xref ref-type="bibr" rid="bib45">Kasper, 2020</xref>; <xref ref-type="bibr" rid="bib83">Wang et al., 2016</xref>). In scRNA-seq, the alarmins S100A8/S100A9 are assigned mainly as marker genes for granulocytes and other phagocytes (<xref ref-type="bibr" rid="bib91">Zheng et al., 2017</xref>). However, expression levels of S100A8/A9 did not differ between the myeloid lineage clusters of B27-AU and B27+ AAU samples.</p><p>The analysis of the cytokine pattern of AqH and sera in the study confirmed previous observations describing elevated IL-18 and IFN-γ levels in the AqH (<xref ref-type="bibr" rid="bib90">Zhao et al., 2015</xref>; <xref ref-type="bibr" rid="bib50">Lacomba et al., 2000</xref>), and an elevated serum IFN-γ level in B27+ AAU patients during active uveitis (<xref ref-type="bibr" rid="bib15">Chen et al., 2015</xref>; <xref ref-type="bibr" rid="bib50">Lacomba et al., 2000</xref>). In particular, IL-18 is a main costimulatory factor for IFN-γ expression in T and NK cells (<xref ref-type="bibr" rid="bib60">Okamura et al., 1995</xref>). Further, the elevated expression of several IFN-γ-related transcripts in B27+ AAU samples matched with previous observations in SpA joint biopsies (<xref ref-type="bibr" rid="bib14">Carlberg et al., 2019</xref>), indicating a IFN-γ-driven immune response during active uveitis.</p><sec id="s3-1"><title>Limitations of the study</title><p>The main limitation of the study is its small sample size combined with a high inter-patient variability influenced by multiple potential confounders (eg, age, sex, disease duration, medication, comorbidities). However, considering the invasiveness of the procedure, the rarity of the disease, and the high costs of sc transcriptomics, our study is relatively sizable. Since both flow cytometry and scRNA-seq were performed with fresh material and since AqH is precious material with limited cell numbers, we were not able to verify several of the hall markers identified with the unbiased scRNA-seq approach. Additional studies that verify the identified genes in a larger cohort will be necessary. Furthermore, the study lacks matched blood data, and we observed an inter-assay variability in some cell populations (eg, granulocytes) between scRNA-seq and flow cytometry. In future studies, multiplex staining with antibodies conjugated to a feature barcode oligonucleotide could improve phenotyping of cells, and an unbiased low-input proteomics analysis will be beneficial to link protein and gene-expression analyses.</p><p>Despite these limitations, our study demonstrates the proof-of-concept feasibility of scRNA-seq of inflammation in AqH, and provides a snapshot of the differences in cellular infiltrate of different uveitis entities and insights into local immune-mediated mechanisms.</p></sec></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Reagent type (species) or resource</th><th align="left" valign="bottom">Designation</th><th align="left" valign="bottom">Source or reference</th><th align="left" valign="bottom">Identifiers</th><th align="left" valign="bottom">Additional information</th></tr></thead><tbody><tr><td align="left" valign="bottom">Biological sample (<italic>Homo sapiens</italic>)</td><td align="left" valign="bottom">Aqueous humor (AqH)</td><td align="left" valign="bottom">Department of Ophthalmology at St Franziskus Hospital, Münster, Germany</td><td align="left" valign="bottom">Deidentified</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Biological sample (<italic>H. sapiens</italic>)</td><td align="left" valign="bottom">Serum</td><td align="left" valign="bottom">Department of Ophthalmology at St Franziskus Hospital, Münster, Germany</td><td align="left" valign="bottom">Deidentified</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-CD3 (mouse monoclonal;OKT3; PerCP-Cy5.5)</td><td align="left" valign="bottom">Biolegend</td><td align="left" valign="bottom">Cat# 317336; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2561628">AB_2561628</ext-link></td><td align="left" valign="bottom">Dilution (1:20)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-CD4 (mouse monoclonal; OKT4;BV510)</td><td align="left" valign="bottom">Biolegend</td><td align="left" valign="bottom">Cat# 317444; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2561866">AB_2561866</ext-link></td><td align="left" valign="bottom">Dilution (1:20)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-CD8a (mouse monoclonal; SK1; APC)</td><td align="left" valign="bottom">Biolegend</td><td align="left" valign="bottom">Cat# 344722; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2075388">AB_2075388</ext-link></td><td align="left" valign="bottom">Dilution (1:20)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-CD11b (rat monoclonal; M1/70; FITC)</td><td align="left" valign="bottom">Biolegend</td><td align="left" valign="bottom">Cat# 101205; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_312788">AB_312788</ext-link></td><td align="left" valign="bottom">Dilution (1:200)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-CD11c (mouse monoclonal; 3.9; Pacific Blue)</td><td align="left" valign="bottom">Biolegend</td><td align="left" valign="bottom">Cat# 301625; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_10662901">AB_10662901</ext-link></td><td align="left" valign="bottom">Dilution (1:20)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-CD56 (mouse monoclonal; N901; PC7)</td><td align="left" valign="bottom">Beckman Coulter</td><td align="left" valign="bottom">Cat# A21692; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2892144">AB_2892144</ext-link></td><td align="left" valign="bottom">Dilution (1:100)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-HLA-DR (mouse monoclonal; Immu-357;ECD)</td><td align="left" valign="bottom">Beckman Coulter</td><td align="left" valign="bottom">Cat# IM3636;RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_10643231">AB_10643231</ext-link></td><td align="left" valign="bottom">Dilution (1:100)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">FcR-blocking reagent, human</td><td align="left" valign="bottom">Miltenyi</td><td align="left" valign="bottom">Cat# 130-059-901; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2892112">AB_2892112</ext-link></td><td align="left" valign="bottom">20 µl/Test</td></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">ProcartaPlex Human Cytokine Panel 1B (25 plex) 96 tests Kit</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">Cat# PX250-12166-901; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2576119">AB_2576119</ext-link></td><td align="left" valign="bottom">Luminex analysis</td></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Chromium Single Cell 3' Library &amp; Gel Bead Kit v2 and v3</td><td align="left" valign="bottom">10x Genomics</td><td align="left" valign="bottom">Cat# PN-120237Cat# PN-1000075</td><td align="left" valign="bottom">RNA-seq analysis</td></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">AMPure XP beads</td><td align="left" valign="bottom">Beckman Coulter</td><td align="left" valign="bottom">Cat# A63881</td><td align="left" valign="bottom">RNA-seq analysis</td></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">NextSeq 500/550 High Output Kit v2.5 (150 cycles)</td><td align="left" valign="bottom">Illumina</td><td align="left" valign="bottom">Cat# 20024907</td><td align="left" valign="bottom">RNA-seq analysis</td></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">NovaSeq 6,000 S4 Reagent Kit v1.5 (300 cycles)</td><td align="left" valign="bottom">Illumina</td><td align="left" valign="bottom">Cat# 20028312</td><td align="left" valign="bottom">RNA-seq analysis</td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">cellranger v3.0.2</td><td align="left" valign="bottom">10x Genomics; <ext-link ext-link-type="uri" xlink:href="https://support.10xgenomics.com/single-cell-gene-expression/software/pipelines/latest/what-is-cell-ranger">https://support.10xgenomics.com/single-cell-gene-expression/software/pipelines/latest/what-is-cell-ranger</ext-link></td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_017344">SCR_017344</ext-link></td><td align="left" valign="bottom">RNA-seq analysis</td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">R Project for Statistical Computing; R v4.0.2</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://www.r-project.org/">https://www.r-project.org/</ext-link></td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_001905">SCR_001905</ext-link></td><td align="left" valign="bottom">RNA-seq analysis; statistical analysis</td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Seurat v3.1.5</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib72">Stuart et al., 2019</xref>; <break/><ext-link ext-link-type="uri" xlink:href="http://seurat.r-forge.r-project.org/">http://seurat.r-forge.r-project.org/</ext-link></td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_007322">SCR_007322</ext-link></td><td align="left" valign="bottom">RNA-seq analysis</td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">HARMONY</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib48">Korsunsky et al., 2019</xref>; <break/><ext-link ext-link-type="uri" xlink:href="https://github.com/immunogenomics/harmony">https://github.com/immunogenomics/harmony</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom">RNA-seq analysis</td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">CellPhoneDB</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib23">Efremova et al., 2020</xref>; <break/><ext-link ext-link-type="uri" xlink:href="https://www.cellphonedb.org/">https://www.cellphonedb.org/</ext-link></td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_017054">SCR_017054</ext-link></td><td align="left" valign="bottom">RNA-seq analysis</td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">EnhancedVolcano.</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib7">Blighe et al., 2018</xref>;<break/><ext-link ext-link-type="uri" xlink:href="https://github.com/kevinblighe/EnhancedVolcano">https://github.com/kevinblighe/EnhancedVolcano</ext-link></td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_018931">SCR_018931</ext-link></td><td align="left" valign="bottom">RNA-seq analysis</td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">cerebroApp</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib36">Hillje et al., 2020</xref>;<break/><ext-link ext-link-type="uri" xlink:href="https://github.com/romanhaa/cerebroApp">https://github.com/romanhaa/cerebroApp</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom">RNA-seq analysis</td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">FACS Kaluza software v2.1.1</td><td align="left" valign="bottom">Beckman Coulter; <ext-link ext-link-type="uri" xlink:href="https://www.beckman.com/coulter-flow-cytometers/software/kaluza">https://www.beckman.com/coulter-flow-cytometers/software/kaluza</ext-link></td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_016182">SCR_016182</ext-link></td><td align="left" valign="bottom">Flow cytometry</td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">FlowJo v10.6.1</td><td align="left" valign="bottom">BD Biosciences; <ext-link ext-link-type="uri" xlink:href="https://www.flowjo.com/solutions/flowjo">https://www.flowjo.com/solutions/flowjo</ext-link></td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_008520">SCR_008520</ext-link></td><td align="left" valign="bottom">Flow cytometry</td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">ProcartaPlex Analyst 1.0 software</td><td align="left" valign="bottom">Thermo Fisher Scientific; <ext-link ext-link-type="uri" xlink:href="https://www.thermofisher.com/de/de/home/global/forms/life-science/procartaplex-analyst-software.html">https://www.thermofisher.com/de/de/home/global/forms/life-science/procartaplex-analyst-software.html</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom">Luminex analysis</td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">MedCalc Statistical Software version 19.3.1</td><td align="left" valign="bottom">MedCalc Software Ltd, Ostend, Belgium; <ext-link ext-link-type="uri" xlink:href="https://www.medcalc.org">https://www.medcalc.org</ext-link>; 2020</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_015044">SCR_015044</ext-link></td><td align="left" valign="bottom">Statistical analysis</td></tr></tbody></table></table-wrap><sec id="s4-1"><title>Patients and inclusion criteria</title><p>Inclusion criteria (all must be fulfilled) were as follows: patients with clinically non-granulomatous AU with an anterior chamber (AC) cell grade &gt;2 + according to SUN guidelines or with infectious endophthalmitis (<xref ref-type="bibr" rid="bib42">Jabs et al., 2005</xref>). Even though patients received topical corticosteroids in previous recurrences, at the time of sampling, patients received no topical anti-inflammatory medication.</p><p>Patients included in the study were classified into the following groups (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1a</xref>). (1) Patients with HLA-B27-associated AAU (B27+ AAU) and with typical clinical signs of AAU. (2) Patients with HLA-B27-negative AU (B27-AU), with typical clinical signs but without inflammatory/immune-mediated systemic disease associated with uveitis. (3) Patients with infectious endophthalmitis. Patients with ages, gender, and systemic medical therapies typical for these three entities were chosen.</p></sec><sec id="s4-2"><title>Laboratory parameters</title><p>The following standard laboratory parameters were tested in all patients: differential blood count, liver and kidney function tests, C-reactive protein, angiotensin-converting enzyme, soluble interleukin 2-receptor, and serological testing for <italic>Treponema pallidum</italic>. The patient was excluded from the study if any of those were remarkable. Patients were analyzed for their HLA-B27 status using established olymerase chain reaction (PCR) (licensed lab standard).</p><p>In addition, patients underwent chest x-ray and consultation with a specialist for internal medicine or rheumatology to identify any associated systemic immune-mediated disease. Patients were classified as having HLA-B27-associated uveitis (eventually with associated systemic disease) if none of the tests except HLA-B27 positivity produced any further findings indicating non-related associated systemic disease. Patients with a clinical appearance of infectious (eg, herpes simplex virus (HSV)- or varicella-zoster virus (VZV)-induced) uveitis or uveitis syndromes (eg, Fuchs uveitis syndrome) were not included in the study.</p></sec><sec id="s4-3"><title>Ophthalmic examinations</title><p>A standardized ophthalmic database was applied for the analysis that included the following parameters: clinical ophthalmic observations on uveitis in the involved eyes were documented according to the SUN criteria (<xref ref-type="bibr" rid="bib42">Jabs et al., 2005</xref>). Briefly, best-corrected visual acuity testing (in LogMAR), slit-lamp examination, Goldmann tonometry, and funduscopy were performed by two independent observers. Any uveitis-related intraocular complications were recorded (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1a</xref>).</p></sec><sec id="s4-4"><title>AqH fine-needle aspirates</title><p>AqH (100–150 µl) was collected from each study subject using a 30 G needle under local anesthesia and immediately shipped at 4°C to the department of neurology at the University Clinic Muenster (Germany) for scRNA-seq and/or flow cytometry analysis. Freshly isolated cells were centrifuged once, counted, and up to 5000 of the input cells were used for scRNA-seq, and the remaining cells were used for flow cytometry. For protein (luminex) analysis, 60 µl of the AqH was centrifuged for 5 min at 12,000×<italic>g</italic> and stored at –80°C until analysis.</p></sec><sec id="s4-5"><title>Single-cell RNA-sequencing and analysis</title><p>Freshly isolated sc suspensions were loaded onto the Chromium Single Cell Controller using the Chromium Single Cell 3' Library &amp; Gel Bead Kit v2 or v3 chemistry (both from 10x Genomics). Sample processing and library preparation were performed according to the manufacturer’s instructions using AMPure XP beads (Beckman Coulter). Sequencing was either carried out on a local Illumina Nextseq 500 using the High-Out 75 cycle kit with a 26-8-0-57 read setup and 150 cycles or commercially (Microanaly, China) on a NovaSeq 6000 using the 300 cycle kit with a paired-end 150 read setup. Sample library kits version and sequencing information are shown in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1b</xref>.</p></sec><sec id="s4-6"><title>Preprocessing of sequencing data</title><p>Processing of sequencing data was performed with the cellranger pipeline v3.0.2 (10x Genomics) according to the manufacturer’s instructions. Raw bcl files were de-multiplexed using the cellranger <italic>mkfastq</italic> pipeline. Subsequent read alignments and transcript counting were done individually for each sample using the cellranger count pipeline with standard parameters. The cellranger <italic>aggr</italic> pipeline was employed to generate an sc barcode matrix containing all the samples without normalization. The normalization of each library was subsequently performed in Seurat (see below).</p></sec><sec id="s4-7"><title>Quality control, normalization, clustering, alignment, and visualization of scRNA-seq data</title><p>Subsequent analysis steps were carried out using Seurat v3.1.5 (<xref ref-type="bibr" rid="bib72">Stuart et al., 2019</xref>) using R v4.0.2 as recommended by the Seurat tutorials. Briefly, cells were filtered to exclude cell doublets and low-quality cells with few genes (&lt;200), high genes (&gt;900–3500), or high mitochondrial percentages (5–7%) in each patient individually. After quality control, the total cell number used for the analysis was 12,305 (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1b</xref>). To account for technical variation, data were normalized using regularized negative binomial regression (<xref ref-type="bibr" rid="bib32">Hafemeister and Satija, 2019</xref>), taking into account mitochondrial percentage and cycle score. Dimensionality reduction was done by principal component analysis. The number of principal components used for the further analysis was determined using an elbow plot. Cells were clustered using the ‘FindNeighbors’ (based on k-nearest neighbor (KNN) graphs) and ‘FindCluster’ (Louvain algorithm) functions in Seurat. To account for batch effects, different samples were aligned using Harmony (<xref ref-type="bibr" rid="bib48">Korsunsky et al., 2019</xref>). The UMAP was then used to visualize cells in a two-dimensional space. Clusters were annotated based on known marker genes.</p></sec><sec id="s4-8"><title>Identifying differentially expressed genes</title><p>The ‘FindMarker’ function in Seurat, which used the Wilcoxon rank sum test, was applied to normalized and aligned data. The threshold of the adjusted p-value was set to 0.05. Volcano plots were created with the R package EnhancedVolcano. DE genes identified by Seurat were used as the input. The threshold for the average log fold change was set at 0.5 and that for p-values at 0.001.</p></sec><sec id="s4-9"><title>Average expression of GWAS risk gene</title><p>Summary statistics were downloaded from the NHGRI-EBI GWAS Catalog (<xref ref-type="bibr" rid="bib13">Buniello et al., 2019</xref>) for the studies GCST007362/GCST007361 (<xref ref-type="bibr" rid="bib65">Robinson et al., 2015</xref>), GCST001345 (<xref ref-type="bibr" rid="bib53">Lin et al., 2011</xref>), GCST000563 (<xref ref-type="bibr" rid="bib3">Australo-Anglo-American Spondyloarthritis Consortium (TASC) et al., 2010</xref>), GCST007361 (<xref ref-type="bibr" rid="bib65">Robinson et al., 2015</xref>), GCST007844 (<xref ref-type="bibr" rid="bib52">Li et al., 2019</xref>), GCST001149 (<xref ref-type="bibr" rid="bib26">Evans et al., 2011</xref>), GCST005529 (<xref ref-type="bibr" rid="bib41">International Genetics of Ankylosing Spondylitis Consortium (IGAS) et al., 2013</xref>), GCST008910 (<xref ref-type="bibr" rid="bib75">Trochet et al., 2019</xref>), GCST003097 (<xref ref-type="bibr" rid="bib24">Ellinghaus et al., 2016</xref>), and GCST010481 (<xref ref-type="bibr" rid="bib37">Huang et al., 2020</xref>) downloaded on 04/09/2020.</p></sec><sec id="s4-10"><title>Identifying cellular interactions</title><p>Cellular interactions were analyzed using CellPhoneDB (<xref ref-type="bibr" rid="bib23">Efremova et al., 2020</xref>). Normalized and aligned scRNA-seq data with the clusters identified by Seurat separated by diagnosis were used for analysis. Clusters with less than 10 cells were excluded. Statistical iterations were set at 1000 and genes expressed by less than 10% of cells in a cluster were removed. Resulting interactions are based on the CellPhoneDB repository. Heatmaps were produced by using the integrated heatmap function and then calculating the difference of the count of significant interactions in condition 1 and condition 2. Dot plots were created with the integrated dot plot function.</p></sec><sec id="s4-11"><title>Flow cytometry of AqH-derived cells</title><p>Flow cytometry analysis was performed on the maximum of recovered cells from the AqH samples (≤10<sup>6</sup> cells). Cells were first blocked with FcR anti-human blocking reagent (Miltenyi). Afterwards, cells were stained for 30 min at 4°C in the dark with a combination of the following anti-human antibodies: CD3 (perCp-Cy5.5, clone OKT3), CD4 (BV510, clone OKT4), CD8 (APC, clone SK1), CD11b (FITC clone M1/70), CD11c (Pacific Blue, clone 3.9)—all from Biolegend—and CD56 (Pe-Cy7, clone N901) and HLA-DR (ECD, clone Immu-357) from Beckman Coulter. Samples were measured on a Gallios (10 colors, 3 lasers; Beckman Coulter) flow cytometer using FACS Kaluza software v2.1.1 (Beckman Coulter). Data were analyzed with FlowJo v10.6.1 (BD Biosciences). The gating strategy is illustrated in <xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2</xref>.</p></sec><sec id="s4-12"><title>Quantification of cytokines in AqH</title><p>Cytokines in AqH samples were quantified via luminex analysis using a ProcartaPlex Human Cytokine-Panel 1B (Thermo Fisher Scientific, Waltham, Massachusetts, USA) that quantifies granulocyte macrophage-colony stimulating factor (GM-CSF), IFN-α, IFN-γ, IL-1α, IL-1β, IL-1RA, IL-2, IL-4, IL-5, IL-6, IL-7, IL-9, IL-10, IL-12p70, IL-13, IL-15, IL-17A, IL-18, IL-21, IL-22, IL-23, IL-27, IL-31, TNF-α, and TNF-β, according to the manufacturer’s instructions. Standards and samples were measured in duplicates using Bio-Plex MAGPIX Multiplex Reader (BioRad, Hercules, California, USA) and cytokines were quantified in (pg/µl) using ProcartaPlex Analyst 1.0 software (Thermo Fisher Scientific).</p></sec></sec></body><back><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn><fn fn-type="COI-statement" id="conf2"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Formal analysis, Investigation, Methodology, Writing – original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con2"><p>Formal analysis, Investigation, Methodology, Visualization, Writing – original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con3"><p>Investigation, Methodology</p></fn><fn fn-type="con" id="con4"><p>Investigation, Methodology</p></fn><fn fn-type="con" id="con5"><p>Investigation, Methodology</p></fn><fn fn-type="con" id="con6"><p>Data curation</p></fn><fn fn-type="con" id="con7"><p>Investigation</p></fn><fn fn-type="con" id="con8"><p>Data curation</p></fn><fn fn-type="con" id="con9"><p>Supervision</p></fn><fn fn-type="con" id="con10"><p>Methodology</p></fn><fn fn-type="con" id="con11"><p>Conceptualization, Data curation, Funding acquisition, Supervision, Writing – original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con12"><p>Conceptualization, Data curation, Funding acquisition, Project administration, Supervision, Writing – original draft, Writing – review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>All patients were recruited at the Department of Ophthalmology at the St. Franziskus Hospital, Muenster, Germany. The study protocol was approved by the local ethics committee of the Medical Association Westphalia-Lippe (AEKWL approval ID 2017-017-f-S). Written informed consent was obtained from all patients before study entry.</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>Supplementary tables.</title><p>(<bold>a</bold>) Clinical data and laboratory analysis. (<bold>b</bold>) Summary of technical information regarding library preparation and sequencing. (<bold>c</bold>) List of top DE genes per cluster in <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref><xref ref-type="fig" rid="fig1">Figure 1</xref>. (<bold>d</bold>) Absolute and relative cluster size in <xref ref-type="fig" rid="fig2">Figure 2</xref>. (<bold>e</bold>) List of DE genes per meta-cluster in <xref ref-type="fig" rid="fig3">Figure 3</xref>. (<bold>f</bold>) List of the DE genes per cluster in <xref ref-type="fig" rid="fig2">Figure 2</xref>. (<bold>g</bold>) GWAS risk genes per meta-cluster in <xref ref-type="fig" rid="fig3">Figure 3G</xref>. (<bold>h</bold>) AqH cytokine level in <xref ref-type="fig" rid="fig4">Figure 4</xref>. (<bold>i</bold>) Cytokine serum level in <xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2</xref>.</p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-67396-supp1-v1.xlsx"/></supplementary-material><supplementary-material id="transrepform"><label>Transparent reporting form</label><media mime-subtype="docx" mimetype="application" xlink:href="elife-67396-transrepform1-v1.docx"/></supplementary-material></sec><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>Raw sequencing data are available in the Gene Expression Omnibus (GEO) repository with the accession code GSE178833 (<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE178833">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE178833</ext-link>). We followed the official tutorial of the packages listed and did not generate any custom code. An interactive version of the scRNA-seq data was created using cerebroApp (Hillje et al., 2020) and is available at: <ext-link ext-link-type="uri" xlink:href="http://uveitis.mheming.de">http://uveitis.mheming.de</ext-link>.</p><p>The following dataset was generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><name><surname>Kasper</surname><given-names>M</given-names></name><name><surname>Heming</surname><given-names>M</given-names></name><name><surname>Heiligenhaus</surname><given-names>A</given-names></name><name><surname>Meyer zu Hörste</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2021">2021</year><data-title>Intraocular dendritic cells characterize HLA-B27-associated acute anterior uveitis</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE178833">GSE178833</pub-id></element-citation></p></sec><ack id="ack"><title>Acknowledgements</title><p>This work was supported by grants from the Deutsche Forschungsgemeinschaft (DFG) to GMzH (ME4050/4-1, ME4050/12-1). GMzH was also supported by the Heisenberg program of the DFG (ME4050/13-1), the DFG grant ME4050/8-1 under the frame of E-Rare-3, the ERA-Net for Research on Rare Diseases, the Grant for Multiple Sclerosis Innovation (Merck), and by a grant from the Ministerium für Innovation, Wissenschaft und Forschung (MIWF) des Landes Nordrhein-Westfalen. MH and GMzH were supported by the Interdisciplinary Center for Clinical Research (IZKF) of the medical faculty of Münster (grant MzH3/020/20 to GMzH and SEED/016/21 to MH). AH was supported in part by the German Society of Ophthalmology (DOG). AH was also supported by Bundesministerium für Bildung und Forschung (BMBF) 01ER1504C, and by a grant from DFG HE 1877/19-1. We thank Dr. Carsten Heinz for patient recruitment and Dr. Susanne Wasmuth for technical assistance.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abu El-Asrar</surname><given-names>AM</given-names></name><name><surname>Berghmans</surname><given-names>N</given-names></name><name><surname>Al-Obeidan</surname><given-names>SA</given-names></name><name><surname>Gikandi</surname><given-names>PW</given-names></name><name><surname>Opdenakker</surname><given-names>G</given-names></name><name><surname>Van Damme</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Local Cytokine Expression Profiling in Patients with Specific Autoimmune Uveitic Entities</article-title><source>Ocular Immunology and Inflammation</source><volume>28</volume><fpage>453</fpage><lpage>462</lpage><pub-id pub-id-type="doi">10.1080/09273948.2019.1604974</pub-id><pub-id pub-id-type="pmid">31161935</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Apte</surname><given-names>RS</given-names></name><name><surname>Sinha</surname><given-names>D</given-names></name><name><surname>Mayhew</surname><given-names>E</given-names></name><name><surname>Wistow</surname><given-names>GJ</given-names></name><name><surname>Niederkorn</surname><given-names>JY</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Cutting edge: role of macrophage migration inhibitory factor in inhibiting NK cell activity and preserving immune privilege</article-title><source>Journal of Immunology</source><volume>160</volume><fpage>5693</fpage><lpage>5696</lpage><pub-id pub-id-type="pmid">9637476</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><collab>Australo-Anglo-American Spondyloarthritis Consortium (TASC)</collab><name><surname>Reveille</surname><given-names>JD</given-names></name><name><surname>Sims</surname><given-names>AM</given-names></name><name><surname>Danoy</surname><given-names>P</given-names></name><name><surname>Evans</surname><given-names>DM</given-names></name><name><surname>Leo</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci</article-title><source>Nature Genetics</source><volume>42</volume><fpage>123</fpage><lpage>127</lpage><pub-id pub-id-type="doi">10.1038/ng.513</pub-id><pub-id pub-id-type="pmid">20062062</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baillet</surname><given-names>A</given-names></name><name><surname>Trocmé</surname><given-names>C</given-names></name><name><surname>Berthier</surname><given-names>S</given-names></name><name><surname>Arlotto</surname><given-names>M</given-names></name><name><surname>Grange</surname><given-names>L</given-names></name><name><surname>Chenau</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Synovial fluid proteomic fingerprint: S100A8, S100A9 and S100A12 proteins discriminate rheumatoid arthritis from other inflammatory joint diseases</article-title><source>Rheumatology</source><volume>49</volume><fpage>671</fpage><lpage>682</lpage><pub-id pub-id-type="doi">10.1093/rheumatology/kep452</pub-id><pub-id pub-id-type="pmid">20100792</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bauer</surname><given-names>D</given-names></name><name><surname>Kasper</surname><given-names>M</given-names></name><name><surname>Walscheid</surname><given-names>K</given-names></name><name><surname>Koch</surname><given-names>JM</given-names></name><name><surname>Müther</surname><given-names>PS</given-names></name><name><surname>Kirchhof</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Multiplex Cytokine Analysis of Aqueous Humor in Juvenile Idiopathic Arthritis-Associated Anterior Uveitis With or Without Secondary Glaucoma</article-title><source>Frontiers in Immunology</source><volume>9</volume><elocation-id>708</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2018.00708</pub-id><pub-id pub-id-type="pmid">29675026</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bauer</surname><given-names>D</given-names></name><name><surname>Kasper</surname><given-names>M</given-names></name><name><surname>Walscheid</surname><given-names>K</given-names></name><name><surname>Koch</surname><given-names>JM</given-names></name><name><surname>Müther</surname><given-names>PS</given-names></name><name><surname>Kirchhof</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Alteration of MCP-1 and MMP-9 in Aqueous Humor Is Associated with Secondary Glaucoma in Fuchs Uveitis Syndrome</article-title><source>Ocular Immunology and Inflammation</source><volume>28</volume><fpage>688</fpage><lpage>698</lpage><pub-id pub-id-type="doi">10.1080/09273948.2019.1609049</pub-id><pub-id pub-id-type="pmid">31268809</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Blighe</surname><given-names>K</given-names></name><name><surname>Rana</surname><given-names>S</given-names></name><name><surname>Lewis</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2018">2018</year><data-title>EnhancedVolcano: Publication-ready volcano plots with enhanced colouring and labeling</data-title><source>GitHub</source><ext-link ext-link-type="uri" xlink:href="https://github.com/kevinblighe/EnhancedVolcano">https://github.com/kevinblighe/EnhancedVolcano</ext-link></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bonacini</surname><given-names>M</given-names></name><name><surname>Soriano</surname><given-names>A</given-names></name><name><surname>Cimino</surname><given-names>L</given-names></name><name><surname>De Simone</surname><given-names>L</given-names></name><name><surname>Bolletta</surname><given-names>E</given-names></name><name><surname>Gozzi</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Cytokine Profiling in Aqueous Humor Samples From Patients With Non-Infectious Uveitis Associated With Systemic Inflammatory Diseases</article-title><source>Frontiers in Immunology</source><volume>11</volume><elocation-id>358</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2020.00358</pub-id><pub-id pub-id-type="pmid">32210963</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borrego</surname><given-names>F</given-names></name><name><surname>Ulbrecht</surname><given-names>M</given-names></name><name><surname>Weiss</surname><given-names>EH</given-names></name><name><surname>Coligan</surname><given-names>JE</given-names></name><name><surname>Brooks</surname><given-names>AG</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis</article-title><source>The Journal of Experimental Medicine</source><volume>187</volume><fpage>813</fpage><lpage>818</lpage><pub-id pub-id-type="doi">10.1084/jem.187.5.813</pub-id><pub-id pub-id-type="pmid">9480992</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bou</surname><given-names>R</given-names></name><name><surname>Adán</surname><given-names>A</given-names></name><name><surname>Borrás</surname><given-names>F</given-names></name><name><surname>Bravo</surname><given-names>B</given-names></name><name><surname>Calvo</surname><given-names>I</given-names></name><name><surname>De Inocencio</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Clinical management algorithm of uveitis associated with juvenile idiopathic arthritis: interdisciplinary panel consensus</article-title><source>Rheumatology International</source><volume>35</volume><fpage>777</fpage><lpage>785</lpage><pub-id pub-id-type="doi">10.1007/s00296-015-3231-3</pub-id><pub-id pub-id-type="pmid">25656443</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brewerton</surname><given-names>DA</given-names></name><name><surname>Caffrey</surname><given-names>M</given-names></name><name><surname>Nicholls</surname><given-names>A</given-names></name><name><surname>Walters</surname><given-names>D</given-names></name><name><surname>James</surname><given-names>DC</given-names></name></person-group><year iso-8601-date="1973">1973</year><article-title>Acute anterior uveitis and HL-A 27</article-title><source>Lancet</source><volume>302</volume><fpage>994</fpage><lpage>996</lpage><pub-id pub-id-type="doi">10.1016/s0140-6736(73)91090-8</pub-id><pub-id pub-id-type="pmid">4127279</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>DP</given-names></name><name><surname>Jones</surname><given-names>DC</given-names></name><name><surname>Anderson</surname><given-names>KJ</given-names></name><name><surname>Lapaque</surname><given-names>N</given-names></name><name><surname>Buerki</surname><given-names>RA</given-names></name><name><surname>Trowsdale</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>The inhibitory receptor LILRB4 (ILT3) modulates antigen presenting cell phenotype and, along with LILRB2 (ILT4), is upregulated in response to Salmonella infection</article-title><source>BMC Immunology</source><volume>10</volume><elocation-id>56</elocation-id><pub-id pub-id-type="doi">10.1186/1471-2172-10-56</pub-id><pub-id pub-id-type="pmid">19860908</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buniello</surname><given-names>A</given-names></name><name><surname>MacArthur</surname><given-names>JAL</given-names></name><name><surname>Cerezo</surname><given-names>M</given-names></name><name><surname>Harris</surname><given-names>LW</given-names></name><name><surname>Hayhurst</surname><given-names>J</given-names></name><name><surname>Malangone</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>The NHGRI-EBI GWAS Catalog of published genome-wide association studies, targeted arrays and summary statistics</article-title><source>Nucleic Acids Research</source><volume>47</volume><fpage>D1005</fpage><lpage>D1012</lpage><pub-id pub-id-type="doi">10.1093/nar/gky1120</pub-id><pub-id pub-id-type="pmid">30445434</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carlberg</surname><given-names>K</given-names></name><name><surname>Korotkova</surname><given-names>M</given-names></name><name><surname>Larsson</surname><given-names>L</given-names></name><name><surname>Catrina</surname><given-names>AI</given-names></name><name><surname>Ståhl</surname><given-names>PL</given-names></name><name><surname>Malmström</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Exploring inflammatory signatures in arthritic joint biopsies with spatial transcriptomics</article-title><source>Scientific Reports</source><volume>9</volume><elocation-id>18975</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-019-55441-y</pub-id><pub-id pub-id-type="pmid">31831833</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>W</given-names></name><name><surname>Zhao</surname><given-names>B</given-names></name><name><surname>Jiang</surname><given-names>R</given-names></name><name><surname>Zhang</surname><given-names>R</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Wu</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Cytokine Expression Profile in Aqueous Humor and Sera of Patients with Acute Anterior Uveitis</article-title><source>Current Molecular Medicine</source><volume>10</volume><fpage>543</fpage><lpage>549</lpage><pub-id pub-id-type="doi">10.2174/1566524015666150731100012</pub-id><pub-id pub-id-type="pmid">26238370</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chronopoulos</surname><given-names>A</given-names></name><name><surname>Roquelaure</surname><given-names>D</given-names></name><name><surname>Souteyrand</surname><given-names>G</given-names></name><name><surname>Seebach</surname><given-names>JD</given-names></name><name><surname>Schutz</surname><given-names>JS</given-names></name><name><surname>Thumann</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Aqueous humor polymerase chain reaction in uveitis – utility and safety</article-title><source>BMC Ophthalmology</source><volume>16</volume><elocation-id>189</elocation-id><pub-id pub-id-type="doi">10.1186/s12886-016-0369-z</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Collin</surname><given-names>M</given-names></name><name><surname>Bigley</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Human dendritic cell subsets: an update</article-title><source>Immunology</source><volume>154</volume><fpage>3</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1111/imm.12888</pub-id><pub-id pub-id-type="pmid">29313948</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crinier</surname><given-names>A</given-names></name><name><surname>Milpied</surname><given-names>P</given-names></name><name><surname>Escalière</surname><given-names>B</given-names></name><name><surname>Piperoglou</surname><given-names>C</given-names></name><name><surname>Galluso</surname><given-names>J</given-names></name><name><surname>Balsamo</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>High-Dimensional Single-Cell Analysis Identifies Organ-Specific Signatures and Conserved NK Cell Subsets in Humans and Mice</article-title><source>Immunity</source><volume>49</volume><fpage>971</fpage><lpage>986</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2018.09.009</pub-id><pub-id pub-id-type="pmid">30413361</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dana</surname><given-names>MR</given-names></name><name><surname>Dai</surname><given-names>R</given-names></name><name><surname>Zhu</surname><given-names>S</given-names></name><name><surname>Yamada</surname><given-names>J</given-names></name><name><surname>Streilein</surname><given-names>JW</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Interleukin-1 receptor antagonist suppresses langerhans cell activity and promotes ocular immune privilege</article-title><source>Investigative Ophthalmology &amp; Visual Science</source><volume>39</volume><fpage>70</fpage><lpage>77</lpage><pub-id pub-id-type="pmid">9430547</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Groot-Mijnes</surname><given-names>JDF</given-names></name><name><surname>Dekkers</surname><given-names>J</given-names></name><name><surname>de Visser</surname><given-names>L</given-names></name><name><surname>Rothova</surname><given-names>A</given-names></name><name><surname>van Loon</surname><given-names>AM</given-names></name><name><surname>de Boer</surname><given-names>JH</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Antibody Production against B19 Virus in Ocular Fluid of JIA-Associated Uveitis Patients</article-title><source>Ophthalmology</source><volume>122</volume><fpage>1270</fpage><lpage>1272</lpage><pub-id pub-id-type="doi">10.1016/j.ophtha.2015.01.006</pub-id><pub-id pub-id-type="pmid">25704320</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Vos</surname><given-names>AF</given-names></name><name><surname>Klaren</surname><given-names>VN</given-names></name><name><surname>Kijlstra</surname><given-names>A</given-names></name></person-group><year iso-8601-date="1994">1994</year><article-title>Expression of multiple cytokines and IL-1RA in the uvea and retina during endotoxin-induced uveitis in the rat</article-title><source>Investigative Ophthalmology &amp; Visual Science</source><volume>35</volume><fpage>3873</fpage><lpage>3883</lpage><pub-id pub-id-type="pmid">7928184</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Denniston</surname><given-names>AK</given-names></name><name><surname>Tomlins</surname><given-names>P</given-names></name><name><surname>Williams</surname><given-names>GP</given-names></name><name><surname>Kottoor</surname><given-names>S</given-names></name><name><surname>Khan</surname><given-names>I</given-names></name><name><surname>Oswal</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Aqueous humor suppression of dendritic cell function helps maintain immune regulation in the eye during human uveitis</article-title><source>Investigative Ophthalmology &amp; Visual Science</source><volume>53</volume><fpage>888</fpage><lpage>896</lpage><pub-id pub-id-type="doi">10.1167/iovs.11-8802</pub-id><pub-id pub-id-type="pmid">22247464</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Efremova</surname><given-names>M</given-names></name><name><surname>Vento-Tormo</surname><given-names>M</given-names></name><name><surname>Teichmann</surname><given-names>SA</given-names></name><name><surname>Vento-Tormo</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>CellPhoneDB: inferring cell-cell communication from combined expression of multi-subunit ligand-receptor complexes</article-title><source>Nature Protocols</source><volume>15</volume><fpage>1484</fpage><lpage>1506</lpage><pub-id pub-id-type="doi">10.1038/s41596-020-0292-x</pub-id><pub-id pub-id-type="pmid">32103204</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ellinghaus</surname><given-names>D</given-names></name><name><surname>Jostins</surname><given-names>L</given-names></name><name><surname>Spain</surname><given-names>SL</given-names></name><name><surname>Cortes</surname><given-names>A</given-names></name><name><surname>Bethune</surname><given-names>J</given-names></name><name><surname>Han</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Analysis of five chronic inflammatory diseases identifies 27 new associations and highlights disease-specific patterns at shared loci</article-title><source>Nature Genetics</source><volume>48</volume><fpage>510</fpage><lpage>518</lpage><pub-id pub-id-type="doi">10.1038/ng.3528</pub-id><pub-id pub-id-type="pmid">26974007</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Engstrom</surname><given-names>RE</given-names></name><name><surname>Mondino</surname><given-names>BJ</given-names></name><name><surname>Glasgow</surname><given-names>BJ</given-names></name><name><surname>Pitchekian-Halabi</surname><given-names>H</given-names></name><name><surname>Adamu</surname><given-names>SA</given-names></name></person-group><year iso-8601-date="1991">1991</year><article-title>Immune response to <italic>Staphylococcus aureus</italic> endophthalmitis in a rabbit model</article-title><source>Investigative Ophthalmology &amp; Visual Science</source><volume>32</volume><fpage>1523</fpage><lpage>1533</lpage><pub-id pub-id-type="pmid">2016134</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Evans</surname><given-names>DM</given-names></name><name><surname>Spencer</surname><given-names>CCA</given-names></name><name><surname>Pointon</surname><given-names>JJ</given-names></name><name><surname>Su</surname><given-names>Z</given-names></name><name><surname>Harvey</surname><given-names>D</given-names></name><name><surname>Kochan</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility</article-title><source>Nature Genetics</source><volume>43</volume><fpage>761</fpage><lpage>767</lpage><pub-id pub-id-type="doi">10.1038/ng.873</pub-id><pub-id pub-id-type="pmid">21743469</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feys</surname><given-names>J</given-names></name><name><surname>Emond</surname><given-names>JP</given-names></name><name><surname>Salvanet-Bouccara</surname><given-names>A</given-names></name><name><surname>Dublanchet</surname><given-names>A</given-names></name></person-group><year iso-8601-date="1994">1994</year><article-title>Interleukin-6 and other cytokines in the aqueous humor in uveitis and endophthalmitis</article-title><source>Journal Francais d’ophtalmologie</source><volume>17</volume><fpage>634</fpage><lpage>639</lpage><pub-id pub-id-type="pmid">7722221</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Figueiredo</surname><given-names>CR</given-names></name><name><surname>Azevedo</surname><given-names>RA</given-names></name><name><surname>Mousdell</surname><given-names>S</given-names></name><name><surname>Resende-Lara</surname><given-names>PT</given-names></name><name><surname>Ireland</surname><given-names>L</given-names></name><name><surname>Santos</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Blockade of MIF-CD74 Signalling on Macrophages and Dendritic Cells Restores the Antitumour Immune Response Against Metastatic Melanoma</article-title><source>Frontiers in Immunology</source><volume>9</volume><elocation-id>1132</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2018.01132</pub-id><pub-id pub-id-type="pmid">29875777</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giese</surname><given-names>MJ</given-names></name><name><surname>Sumner</surname><given-names>HL</given-names></name><name><surname>Berliner</surname><given-names>A</given-names></name><name><surname>Mondino</surname><given-names>BJ</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Cytokine expression in a rat model of <italic>Staphylococcus aureus</italic> endophthalmitis</article-title><source>Investigative Ophthalmology &amp; Visual Science</source><volume>39</volume><fpage>2785</fpage><lpage>2790</lpage><pub-id pub-id-type="pmid">9856792</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gómez-Gómez</surname><given-names>A</given-names></name><name><surname>Loza</surname><given-names>E</given-names></name><name><surname>Rosario</surname><given-names>MP</given-names></name><name><surname>Espinosa</surname><given-names>G</given-names></name><name><surname>de</surname><given-names>MJ</given-names></name><name><surname>Herreras</surname><given-names>JM</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Efficacy and safety of immunomodulatory drugs in patients with anterior uveitis: A systematic literature review</article-title><source>Medicine</source><volume>96</volume><elocation-id>e8045</elocation-id><pub-id pub-id-type="doi">10.1097/MD.0000000000008045</pub-id><pub-id pub-id-type="pmid">29049193</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Greiner</surname><given-names>K</given-names></name><name><surname>Amer</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>The role of cytokines for the diagnosis of uveitis</article-title><source>Klinische Monatsblatter Fur Augenheilkunde</source><volume>225</volume><fpage>564</fpage><lpage>569</lpage><pub-id pub-id-type="doi">10.1055/s-2008-1027452</pub-id><pub-id pub-id-type="pmid">18516777</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hafemeister</surname><given-names>C</given-names></name><name><surname>Satija</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Normalization and variance stabilization of single-cell RNA-seq data using regularized negative binomial regression</article-title><source>Genome Biology</source><volume>20</volume><elocation-id>296</elocation-id><pub-id pub-id-type="doi">10.1186/s13059-019-1874-1</pub-id><pub-id pub-id-type="pmid">31870423</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hao</surname><given-names>X</given-names></name><name><surname>Yi</surname><given-names>C</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Huang</surname><given-names>F</given-names></name><name><surname>He</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Identification of intraocular inflammatory mediators in patients with endophthalmitis</article-title><source>Molecular Vision</source><volume>22</volume><fpage>563</fpage><lpage>574</lpage><pub-id pub-id-type="pmid">27293374</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heiligenhaus</surname><given-names>A</given-names></name><name><surname>Michels</surname><given-names>H</given-names></name><name><surname>Schumacher</surname><given-names>C</given-names></name><name><surname>Kopp</surname><given-names>I</given-names></name><name><surname>Neudorf</surname><given-names>U</given-names></name><name><surname>Niehues</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Evidence-based, interdisciplinary guidelines for anti-inflammatory treatment of uveitis associated with juvenile idiopathic arthritis</article-title><source>Rheumatology International</source><volume>32</volume><fpage>1121</fpage><lpage>1133</lpage><pub-id pub-id-type="doi">10.1007/s00296-011-2126-1</pub-id><pub-id pub-id-type="pmid">22083610</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heming</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Räuber</surname><given-names>S</given-names></name><name><surname>Mausberg</surname><given-names>AK</given-names></name><name><surname>Börsch</surname><given-names>AL</given-names></name><name><surname>Hartlehnert</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Neurological Manifestations of COVID-19 Feature T Cell Exhaustion and Dedifferentiated Monocytes in Cerebrospinal Fluid</article-title><source>Immunity</source><volume>54</volume><fpage>164</fpage><lpage>175</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2020.12.011</pub-id><pub-id pub-id-type="pmid">33382973</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hillje</surname><given-names>R</given-names></name><name><surname>Pelicci</surname><given-names>PG</given-names></name><name><surname>Luzi</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Cerebro: interactive visualization of scRNA-seq data</article-title><source>Bioinformatics</source><volume>36</volume><fpage>2311</fpage><lpage>2313</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btz877</pub-id><pub-id pub-id-type="pmid">31764967</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>XF</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>De Guzman</surname><given-names>E</given-names></name><name><surname>Robinson</surname><given-names>P</given-names></name><name><surname>Gensler</surname><given-names>L</given-names></name><name><surname>Ward</surname><given-names>MM</given-names></name><name><surname>Rahbar</surname><given-names>MH</given-names></name><name><surname>Lee</surname><given-names>M</given-names></name><name><surname>Weisman</surname><given-names>MH</given-names></name><name><surname>Macfarlane</surname><given-names>GJ</given-names></name><name><surname>Jones</surname><given-names>GT</given-names></name><name><surname>Klingberg</surname><given-names>E</given-names></name><name><surname>Forsblad-d’Elia</surname><given-names>H</given-names></name><name><surname>McCluskey</surname><given-names>P</given-names></name><name><surname>Wakefield</surname><given-names>D</given-names></name><name><surname>Coombes</surname><given-names>JS</given-names></name><name><surname>Fiatarone Singh</surname><given-names>MA</given-names></name><name><surname>Mavros</surname><given-names>Y</given-names></name><name><surname>Vlahovich</surname><given-names>N</given-names></name><name><surname>Hughes</surname><given-names>DC</given-names></name><name><surname>Marzo-Ortega</surname><given-names>H</given-names></name><name><surname>Van der Horste-Bruinsma</surname><given-names>I</given-names></name><name><surname>O’Shea</surname><given-names>F</given-names></name><name><surname>Martin</surname><given-names>TM</given-names></name><name><surname>Rosenbaum</surname><given-names>J</given-names></name><name><surname>Breban</surname><given-names>M</given-names></name><name><surname>Jin</surname><given-names>ZB</given-names></name><name><surname>Leo</surname><given-names>P</given-names></name><name><surname>Reveille</surname><given-names>JD</given-names></name><name><surname>Wordsworth</surname><given-names>BP</given-names></name><name><surname>Brown</surname><given-names>MA</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Genomewide association study of acute anterior Uveitis identifies new susceptibility loci</article-title><source>Vestigative Opthalmology &amp; Visual Science</source><volume>61</volume><fpage>3</fpage><pub-id pub-id-type="doi">10.1167/iovs.61.6.3</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huhtinen</surname><given-names>M</given-names></name><name><surname>Karma</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>HLA-B27 typing in the categorisation of uveitis in a HLA-B27 rich population</article-title><source>The British Journal of Ophthalmology</source><volume>84</volume><fpage>413</fpage><lpage>416</lpage><pub-id pub-id-type="doi">10.1136/bjo.84.4.413</pub-id><pub-id pub-id-type="pmid">10729301</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huhtinen</surname><given-names>M</given-names></name><name><surname>Laasila</surname><given-names>K</given-names></name><name><surname>Granfors</surname><given-names>K</given-names></name><name><surname>Puolakkainen</surname><given-names>M</given-names></name><name><surname>Seppälä</surname><given-names>I</given-names></name><name><surname>Laasonen</surname><given-names>L</given-names></name><name><surname>Repo</surname><given-names>H</given-names></name><name><surname>Karma</surname><given-names>A</given-names></name><name><surname>Leirisalo-Repo</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2002">2002a</year><article-title>Infectious background of patients with a history of acute anterior uveitis</article-title><source>Annals of the Rheumatic Diseases</source><volume>61</volume><fpage>1012</fpage><lpage>1016</lpage><pub-id pub-id-type="doi">10.1136/ard.61.11.1012</pub-id><pub-id pub-id-type="pmid">12379526</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huhtinen</surname><given-names>M</given-names></name><name><surname>Repo</surname><given-names>H</given-names></name><name><surname>Laasila</surname><given-names>K</given-names></name><name><surname>Jansson</surname><given-names>SE</given-names></name><name><surname>Kautiainen</surname><given-names>H</given-names></name><name><surname>Karma</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2002">2002b</year><article-title>Systemic inflammation and innate immune response in patients with previous anterior uveitis</article-title><source>The British Journal of Ophthalmology</source><volume>86</volume><fpage>412</fpage><lpage>417</lpage><pub-id pub-id-type="doi">10.1136/bjo.86.4.412</pub-id><pub-id pub-id-type="pmid">11914210</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><collab>International Genetics of Ankylosing Spondylitis Consortium (IGAS)</collab><name><surname>Cortes</surname><given-names>A</given-names></name><name><surname>Hadler</surname><given-names>J</given-names></name><name><surname>Pointon</surname><given-names>JP</given-names></name><name><surname>Robinson</surname><given-names>PC</given-names></name><name><surname>Karaderi</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci</article-title><source>Nature Genetics</source><volume>45</volume><fpage>730</fpage><lpage>738</lpage><pub-id pub-id-type="doi">10.1038/ng.2667</pub-id><pub-id pub-id-type="pmid">23749187</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jabs</surname><given-names>DA</given-names></name><name><surname>Nussenblatt</surname><given-names>RB</given-names></name><name><surname>Rosenbaum</surname><given-names>JT</given-names></name><collab>Standardization of Uveitis Nomenclature (SUN) Working Group</collab></person-group><year iso-8601-date="2005">2005</year><article-title>Standardization of uveitis nomenclature for reporting clinical data</article-title><source>American Journal of Ophthalmology</source><volume>140</volume><fpage>509</fpage><lpage>516</lpage><pub-id pub-id-type="doi">10.1016/j.ajo.2005.03.057</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>FM</given-names></name><name><surname>Shur</surname><given-names>BD</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>The level of cell surface beta1,4-galactosyltransferase I influences the invasive potential of murine melanoma cells</article-title><source>Journal of Cell Science</source><volume>112</volume><fpage>2785</fpage><lpage>2795</lpage><pub-id pub-id-type="doi">10.1242/jcs.112.16.2785</pub-id><pub-id pub-id-type="pmid">10413685</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kasper</surname><given-names>M</given-names></name><name><surname>Walscheid</surname><given-names>K</given-names></name><name><surname>Laffer</surname><given-names>B</given-names></name><name><surname>Bauer</surname><given-names>D</given-names></name><name><surname>Busch</surname><given-names>M</given-names></name><name><surname>Wildschütz</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>B</given-names></name><name><surname>Loser</surname><given-names>K</given-names></name><name><surname>Vogl</surname><given-names>T</given-names></name><name><surname>Grajewski</surname><given-names>RS</given-names></name><name><surname>Langmann</surname><given-names>T</given-names></name><name><surname>Heiligenhaus</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>The phenotype of monocytes in anterior uveitis depends on the hla-b27 status</article-title><source>Frontiers in Immunology</source><volume>9</volume><elocation-id>1773</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2018.01773</pub-id><pub-id pub-id-type="pmid">30105034</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kasper</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Phenotype of innate immune cells in uveitis associated with axial spondyloarthritis- and juvenile idiopathic arthritis-associated uveitis</article-title><source>Ocular Immunology and Inflammation</source><volume>11</volume><fpage>1</fpage><lpage>10</lpage></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khan</surname><given-names>MA</given-names></name><name><surname>Haroon</surname><given-names>M</given-names></name><name><surname>Rosenbaum</surname><given-names>JT</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Acute anterior uveitis and spondyloarthritis: more than meets the eye</article-title><source>Current Rheumatology Reports</source><volume>17</volume><elocation-id>59</elocation-id><pub-id pub-id-type="doi">10.1007/s11926-015-0536-x</pub-id><pub-id pub-id-type="pmid">26233598</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kopplin</surname><given-names>LJ</given-names></name><name><surname>Mount</surname><given-names>G</given-names></name><name><surname>Suhler</surname><given-names>EB</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Review for Disease of the Year: Epidemiology of HLA-B27 Associated Ocular Disorders</article-title><source>Ocular Immunology and Inflammation</source><volume>24</volume><fpage>470</fpage><lpage>475</lpage><pub-id pub-id-type="doi">10.1080/09273948.2016.1175642</pub-id><pub-id pub-id-type="pmid">27232197</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Korsunsky</surname><given-names>I</given-names></name><name><surname>Millard</surname><given-names>N</given-names></name><name><surname>Fan</surname><given-names>J</given-names></name><name><surname>Slowikowski</surname><given-names>K</given-names></name><name><surname>Zhang</surname><given-names>F</given-names></name><name><surname>Wei</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Fast, sensitive and accurate integration of single-cell data with Harmony</article-title><source>Nature Methods</source><volume>16</volume><fpage>1289</fpage><lpage>1296</lpage><pub-id pub-id-type="doi">10.1038/s41592-019-0619-0</pub-id><pub-id pub-id-type="pmid">31740819</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kwon</surname><given-names>OC</given-names></name><name><surname>Lee</surname><given-names>EJ</given-names></name><name><surname>Lee</surname><given-names>JY</given-names></name><name><surname>Youn</surname><given-names>J</given-names></name><name><surname>Kim</surname><given-names>TH</given-names></name><name><surname>Hong</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Prefoldin 5 and Anti-prefoldin 5 Antibodies as Biomarkers for Uveitis in Ankylosing Spondylitis</article-title><source>Frontiers in Immunology</source><volume>10</volume><elocation-id>384</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2019.00384</pub-id><pub-id pub-id-type="pmid">30891043</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lacomba</surname><given-names>MS</given-names></name><name><surname>Martin</surname><given-names>CM</given-names></name><name><surname>Chamond</surname><given-names>RR</given-names></name><name><surname>Galera</surname><given-names>JM</given-names></name><name><surname>Omar</surname><given-names>M</given-names></name><name><surname>Estevez</surname><given-names>EC</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Aqueous and serum interferon gamma, interleukin (IL) 2, IL-4, and IL-10 in patients with uveitis</article-title><source>Archives of Ophthalmology</source><volume>118</volume><fpage>768</fpage><lpage>772</lpage><pub-id pub-id-type="doi">10.1001/archopht.118.6.768</pub-id><pub-id pub-id-type="pmid">10865312</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lam</surname><given-names>MT</given-names></name><name><surname>Coppola</surname><given-names>S</given-names></name><name><surname>Krumbach</surname><given-names>OHF</given-names></name><name><surname>Prencipe</surname><given-names>G</given-names></name><name><surname>Insalaco</surname><given-names>A</given-names></name><name><surname>Cifaldi</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>A novel disorder involving dyshematopoiesis, inflammation, and HLH due to aberrant CDC42 function</article-title><source>The Journal of Experimental Medicine</source><volume>216</volume><fpage>2778</fpage><lpage>2799</lpage><pub-id pub-id-type="doi">10.1084/jem.20190147</pub-id><pub-id pub-id-type="pmid">31601675</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Akar</surname><given-names>S</given-names></name><name><surname>Yarkan</surname><given-names>H</given-names></name><name><surname>Lee</surname><given-names>SK</given-names></name><name><surname>Çetin</surname><given-names>P</given-names></name><name><surname>Can</surname><given-names>G</given-names></name><name><surname>Kenar</surname><given-names>G</given-names></name><name><surname>Çapa</surname><given-names>F</given-names></name><name><surname>Pamuk</surname><given-names>ON</given-names></name><name><surname>Pehlivan</surname><given-names>Y</given-names></name><name><surname>Cremin</surname><given-names>K</given-names></name><name><surname>De Guzman</surname><given-names>E</given-names></name><name><surname>Harris</surname><given-names>J</given-names></name><name><surname>Wheeler</surname><given-names>L</given-names></name><name><surname>Jamshidi</surname><given-names>A</given-names></name><name><surname>Vojdanian</surname><given-names>M</given-names></name><name><surname>Farhadi</surname><given-names>E</given-names></name><name><surname>Ahmadzadeh</surname><given-names>N</given-names></name><name><surname>Yüce</surname><given-names>Z</given-names></name><name><surname>Dalkılıç</surname><given-names>E</given-names></name><name><surname>Solmaz</surname><given-names>D</given-names></name><name><surname>Akın</surname><given-names>B</given-names></name><name><surname>Dönmez</surname><given-names>S</given-names></name><name><surname>Sarı</surname><given-names>İ</given-names></name><name><surname>Leo</surname><given-names>PJ</given-names></name><name><surname>Kenna</surname><given-names>TJ</given-names></name><name><surname>Önen</surname><given-names>F</given-names></name><name><surname>Mahmoudi</surname><given-names>M</given-names></name><name><surname>Brown</surname><given-names>MA</given-names></name><name><surname>Akkoc</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Genome-wide association study in turkish and iranian populations identify rare familial Mediterranean fever gene (MEFV) polymorphisms associated with ankylosing spondylitis</article-title><source>PLOS Genetics</source><volume>15</volume><elocation-id>e1008038</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1008038</pub-id><pub-id pub-id-type="pmid">30946743</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>Z</given-names></name><name><surname>Bei</surname><given-names>JX</given-names></name><name><surname>Shen</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>Q</given-names></name><name><surname>Liao</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>A genome-wide association study in Han Chinese identifies new susceptibility loci for ankylosing spondylitis</article-title><source>Nature Genetics</source><volume>44</volume><fpage>73</fpage><lpage>77</lpage><pub-id pub-id-type="doi">10.1038/ng.1005</pub-id><pub-id pub-id-type="pmid">22138694</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>B</given-names></name><name><surname>Dhanda</surname><given-names>A</given-names></name><name><surname>Hirani</surname><given-names>S</given-names></name><name><surname>Williams</surname><given-names>EL</given-names></name><name><surname>Sen</surname><given-names>HN</given-names></name><name><surname>Martinez Estrada</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>CD14++CD16+ monocytes are enriched by glucocorticoid treatment and are functionally attenuated in driving effector T cell responses</article-title><source>Journal of Immunology</source><volume>194</volume><fpage>5150</fpage><lpage>5160</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1402409</pub-id><pub-id pub-id-type="pmid">25911752</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Ding</surname><given-names>J</given-names></name><name><surname>Tong</surname><given-names>Z</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Calreticulin acts as an adjuvant to promote dendritic cell maturation and enhances antigen-specific cytotoxic T lymphocyte responses against non-small cell lung cancer cells</article-title><source>Cellular Immunology</source><volume>300</volume><fpage>46</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.1016/j.cellimm.2015.12.003</pub-id><pub-id pub-id-type="pmid">26702740</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maillet</surname><given-names>J</given-names></name><name><surname>Ottaviani</surname><given-names>S</given-names></name><name><surname>Tubach</surname><given-names>F</given-names></name><name><surname>Roy</surname><given-names>C</given-names></name><name><surname>Nicaise-Rolland</surname><given-names>P</given-names></name><name><surname>Palazzo</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Anti-<italic>Saccharomyces cerevisiae</italic> antibodies (ASCA) in spondyloarthritis: Prevalence and associated phenotype</article-title><source>Joint, Bone, Spine</source><volume>83</volume><fpage>665</fpage><lpage>668</lpage><pub-id pub-id-type="doi">10.1016/j.jbspin.2015.10.011</pub-id><pub-id pub-id-type="pmid">26992953</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Merad</surname><given-names>M</given-names></name><name><surname>Sathe</surname><given-names>P</given-names></name><name><surname>Helft</surname><given-names>J</given-names></name><name><surname>Miller</surname><given-names>J</given-names></name><name><surname>Mortha</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting</article-title><source>Annual Review of Immunology</source><volume>31</volume><fpage>563</fpage><lpage>604</lpage><pub-id pub-id-type="doi">10.1146/annurev-immunol-020711-074950</pub-id><pub-id pub-id-type="pmid">23516985</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miyamoto</surname><given-names>N</given-names></name><name><surname>Mandai</surname><given-names>M</given-names></name><name><surname>Suzuma</surname><given-names>I</given-names></name><name><surname>Suzuma</surname><given-names>K</given-names></name><name><surname>Kobayashi</surname><given-names>K</given-names></name><name><surname>Honda</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Estrogen protects against cellular infiltration by reducing the expressions of e-selectin and il-6 in endotoxin-induced uveitis</article-title><source>Journal of Immunology</source><volume>163</volume><fpage>374</fpage><lpage>379</lpage><pub-id pub-id-type="pmid">10384138</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nussenblatt</surname><given-names>RB</given-names></name><name><surname>Palestine</surname><given-names>AG</given-names></name><name><surname>Chan</surname><given-names>CC</given-names></name><name><surname>Stevens</surname><given-names>G</given-names></name><name><surname>Mellow</surname><given-names>SD</given-names></name><name><surname>Green</surname><given-names>SB</given-names></name></person-group><year iso-8601-date="1991">1991</year><article-title>Randomized, double-masked study of cyclosporine compared to prednisolone in the treatment of endogenous uveitis</article-title><source>American Journal of Ophthalmology</source><volume>112</volume><fpage>138</fpage><lpage>146</lpage><pub-id pub-id-type="doi">10.1016/s0002-9394(14)76692-9</pub-id><pub-id pub-id-type="pmid">1867297</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okamura</surname><given-names>H</given-names></name><name><surname>Tsutsi</surname><given-names>H</given-names></name><name><surname>Komatsu</surname><given-names>T</given-names></name><name><surname>Yutsudo</surname><given-names>M</given-names></name><name><surname>Hakura</surname><given-names>A</given-names></name><name><surname>Tanimoto</surname><given-names>T</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Cloning of a new cytokine that induces IFN-gamma production by T cells</article-title><source>Nature</source><volume>378</volume><fpage>88</fpage><lpage>91</lpage><pub-id pub-id-type="doi">10.1038/378088a0</pub-id><pub-id pub-id-type="pmid">7477296</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peterson</surname><given-names>VM</given-names></name><name><surname>Zhang</surname><given-names>KX</given-names></name><name><surname>Kumar</surname><given-names>N</given-names></name><name><surname>Wong</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Wilson</surname><given-names>DC</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Multiplexed quantification of proteins and transcripts in single cells</article-title><source>Nature Biotechnology</source><volume>7</volume><fpage>936</fpage><lpage>939</lpage><pub-id pub-id-type="doi">10.1038/nbt.3973</pub-id><pub-id pub-id-type="pmid">28854175</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Planck</surname><given-names>SR</given-names></name><name><surname>Woods</surname><given-names>A</given-names></name><name><surname>Clowers</surname><given-names>JS</given-names></name><name><surname>Nicklin</surname><given-names>MJ</given-names></name><name><surname>Rosenbaum</surname><given-names>JT</given-names></name><name><surname>Rosenzweig</surname><given-names>HL</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Impact of IL-1 signalling on experimental uveitis and arthritis</article-title><source>Annals of the Rheumatic Diseases</source><volume>71</volume><fpage>753</fpage><lpage>760</lpage><pub-id pub-id-type="doi">10.1136/annrheumdis-2011-200556</pub-id><pub-id pub-id-type="pmid">22267332</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pruenster</surname><given-names>M</given-names></name><name><surname>Vogl</surname><given-names>T</given-names></name><name><surname>Roth</surname><given-names>J</given-names></name><name><surname>Sperandio</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>S100A8/A9: From basic science to clinical application</article-title><source>Pharmacology &amp; Therapeutics</source><volume>167</volume><fpage>120</fpage><lpage>131</lpage><pub-id pub-id-type="doi">10.1016/j.pharmthera.2016.07.015</pub-id><pub-id pub-id-type="pmid">27492899</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rijvers</surname><given-names>L</given-names></name><name><surname>Melief</surname><given-names>MJ</given-names></name><name><surname>van Langelaar</surname><given-names>J</given-names></name><name><surname>van der Vuurst de Vries</surname><given-names>RM</given-names></name><name><surname>Wierenga-Wolf</surname><given-names>AF</given-names></name><name><surname>Koetzier</surname><given-names>SC</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>The Role of Autoimmunity-Related Gene CLEC16A in the B Cell Receptor-Mediated HLA Class II Pathway</article-title><source>Journal of Immunology</source><volume>205</volume><fpage>945</fpage><lpage>956</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1901409</pub-id><pub-id pub-id-type="pmid">32641384</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robinson</surname><given-names>PC</given-names></name><name><surname>Claushuis</surname><given-names>TAM</given-names></name><name><surname>Cortes</surname><given-names>A</given-names></name><name><surname>Martin</surname><given-names>TM</given-names></name><name><surname>Evans</surname><given-names>DM</given-names></name><name><surname>Leo</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Genetic dissection of acute anterior uveitis reveals similarities and differences in associations observed with ankylosing spondylitis</article-title><source>Arthritis Rheumatol</source><volume>67</volume><fpage>140</fpage><lpage>151</lpage><pub-id pub-id-type="doi">10.1002/art.38873</pub-id><pub-id pub-id-type="pmid">25200001</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosenbaum</surname><given-names>JT</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Uveitis in spondyloarthritis including psoriatic arthritis, ankylosing spondylitis, and inflammatory bowel disease</article-title><source>Clinical Rheumatology</source><volume>34</volume><fpage>999</fpage><lpage>1002</lpage><pub-id pub-id-type="doi">10.1007/s10067-015-2960-8</pub-id><pub-id pub-id-type="pmid">25953065</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosenbaum</surname><given-names>JT</given-names></name><name><surname>Asquith</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>The microbiome and HLA-B27-associated acute anterior uveitis</article-title><source>Nature Reviews. Rheumatology</source><volume>14</volume><fpage>704</fpage><lpage>713</lpage><pub-id pub-id-type="doi">10.1038/s41584-018-0097-2</pub-id><pub-id pub-id-type="pmid">30301938</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rothova</surname><given-names>A</given-names></name><name><surname>Suttorp-van Schulten</surname><given-names>MS</given-names></name><name><surname>Frits Treffers</surname><given-names>W</given-names></name><name><surname>Kijlstra</surname><given-names>A</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Causes and frequency of blindness in patients with intraocular inflammatory disease</article-title><source>The British Journal of Ophthalmology</source><volume>80</volume><fpage>332</fpage><lpage>336</lpage><pub-id pub-id-type="doi">10.1136/bjo.80.4.332</pub-id><pub-id pub-id-type="pmid">8703885</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schafflick</surname><given-names>D</given-names></name><name><surname>Ca</surname><given-names>X</given-names></name><name><surname>Hartlehnert</surname><given-names>M</given-names></name><name><surname>Cole</surname><given-names>M</given-names></name><name><surname>Schulte-Mecklenbeck</surname><given-names>A</given-names></name><name><surname>Lautwein</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis</article-title><source>Nature Communications</source><volume>11</volume><elocation-id>247</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-019-14118-w</pub-id><pub-id pub-id-type="pmid">31937773</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scutera</surname><given-names>S</given-names></name><name><surname>Fraone</surname><given-names>T</given-names></name><name><surname>Musso</surname><given-names>T</given-names></name><name><surname>Cappello</surname><given-names>P</given-names></name><name><surname>Rossi</surname><given-names>S</given-names></name><name><surname>Pierobon</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Survival and migration of human dendritic cells are regulated by an IFN-alpha-inducible Axl/Gas6 pathway</article-title><source>Journal of Immunology</source><volume>183</volume><fpage>3004</fpage><lpage>3013</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.0804384</pub-id><pub-id pub-id-type="pmid">19657094</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stephenson</surname><given-names>W</given-names></name><name><surname>Donlin</surname><given-names>LT</given-names></name><name><surname>Butler</surname><given-names>A</given-names></name><name><surname>Rozo</surname><given-names>C</given-names></name><name><surname>Bracken</surname><given-names>B</given-names></name><name><surname>Rashidfarrokhi</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Single-cell RNA-seq of rheumatoid arthritis synovial tissue using low-cost microfluidic instrumentation</article-title><source>Nature Communications</source><volume>9</volume><elocation-id>791</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-017-02659-x</pub-id><pub-id pub-id-type="pmid">29476078</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stuart</surname><given-names>T</given-names></name><name><surname>Butler</surname><given-names>A</given-names></name><name><surname>Hoffman</surname><given-names>P</given-names></name><name><surname>Hafemeister</surname><given-names>C</given-names></name><name><surname>Papalexi</surname><given-names>E</given-names></name><name><surname>Mauck</surname><given-names>WM</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Comprehensive Integration of Single-Cell Data</article-title><source>Cell</source><volume>177</volume><fpage>1888</fpage><lpage>1902</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2019.05.031</pub-id><pub-id pub-id-type="pmid">31178118</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taurog</surname><given-names>JD</given-names></name><name><surname>Richardson</surname><given-names>JA</given-names></name><name><surname>Croft</surname><given-names>JT</given-names></name><name><surname>Simmons</surname><given-names>WA</given-names></name><name><surname>Zhou</surname><given-names>M</given-names></name><name><surname>Fernández-Sueiro</surname><given-names>JL</given-names></name></person-group><year iso-8601-date="1994">1994</year><article-title>The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats</article-title><source>The Journal of Experimental Medicine</source><volume>180</volume><fpage>2359</fpage><lpage>2364</lpage><pub-id pub-id-type="doi">10.1084/jem.180.6.2359</pub-id><pub-id pub-id-type="pmid">7964509</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thorne</surname><given-names>JE</given-names></name><name><surname>Suhler</surname><given-names>E</given-names></name><name><surname>Skup</surname><given-names>M</given-names></name><name><surname>Tari</surname><given-names>S</given-names></name><name><surname>Macaulay</surname><given-names>D</given-names></name><name><surname>Chao</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Prevalence of Noninfectious Uveitis in the United States: A Claims-Based Analysis</article-title><source>JAMA Ophthalmology</source><volume>134</volume><fpage>1237</fpage><lpage>1245</lpage><pub-id pub-id-type="doi">10.1001/jamaophthalmol.2016.3229</pub-id><pub-id pub-id-type="pmid">27608193</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trochet</surname><given-names>H</given-names></name><name><surname>Pirinen</surname><given-names>M</given-names></name><name><surname>Band</surname><given-names>G</given-names></name><name><surname>Jostins</surname><given-names>L</given-names></name><name><surname>McVean</surname><given-names>G</given-names></name><name><surname>Spencer</surname><given-names>CCA</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Bayesian meta-analysis across genome-wide association studies of diverse phenotypes</article-title><source>Genetic Epidemiology</source><volume>43</volume><fpage>532</fpage><lpage>547</lpage><pub-id pub-id-type="doi">10.1002/gepi.22202</pub-id><pub-id pub-id-type="pmid">30920090</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uniken Venema</surname><given-names>WT</given-names></name><name><surname>Voskuil</surname><given-names>MD</given-names></name><name><surname>Vila</surname><given-names>AV</given-names></name><name><surname>van der Vries</surname><given-names>G</given-names></name><name><surname>Jansen</surname><given-names>BH</given-names></name><name><surname>Jabri</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Single-Cell RNA Sequencing of Blood and Ileal T Cells From Patients With Crohn’s Disease Reveals Tissue-Specific Characteristics and Drug Targets</article-title><source>Gastroenterology</source><volume>156</volume><fpage>812</fpage><lpage>815</lpage><pub-id pub-id-type="doi">10.1053/j.gastro.2018.10.046</pub-id><pub-id pub-id-type="pmid">30391472</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vieth</surname><given-names>B</given-names></name><name><surname>Parekh</surname><given-names>S</given-names></name><name><surname>Ziegenhain</surname><given-names>C</given-names></name><name><surname>Enard</surname><given-names>W</given-names></name><name><surname>Hellmann</surname><given-names>I</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>A systematic evaluation of single cell RNA-seq analysis pipelines</article-title><source>Nature Communications</source><volume>10</volume><elocation-id>4667</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-019-12266-7</pub-id><pub-id pub-id-type="pmid">31604912</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Villani</surname><given-names>A-C</given-names></name><name><surname>Satija</surname><given-names>R</given-names></name><name><surname>Reynolds</surname><given-names>G</given-names></name><name><surname>Sarkizova</surname><given-names>S</given-names></name><name><surname>Shekhar</surname><given-names>K</given-names></name><name><surname>Fletcher</surname><given-names>J</given-names></name><name><surname>Griesbeck</surname><given-names>M</given-names></name><name><surname>Butler</surname><given-names>A</given-names></name><name><surname>Zheng</surname><given-names>S</given-names></name><name><surname>Lazo</surname><given-names>S</given-names></name><name><surname>Jardine</surname><given-names>L</given-names></name><name><surname>Dixon</surname><given-names>D</given-names></name><name><surname>Stephenson</surname><given-names>E</given-names></name><name><surname>Nilsson</surname><given-names>E</given-names></name><name><surname>Grundberg</surname><given-names>I</given-names></name><name><surname>McDonald</surname><given-names>D</given-names></name><name><surname>Filby</surname><given-names>A</given-names></name><name><surname>Li</surname><given-names>W</given-names></name><name><surname>De Jager</surname><given-names>PL</given-names></name><name><surname>Rozenblatt-Rosen</surname><given-names>O</given-names></name><name><surname>Lane</surname><given-names>AA</given-names></name><name><surname>Haniffa</surname><given-names>M</given-names></name><name><surname>Regev</surname><given-names>A</given-names></name><name><surname>Hacohen</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors</article-title><source>Science</source><volume>356</volume><elocation-id>eaah4573</elocation-id><pub-id pub-id-type="doi">10.1126/science.aah4573</pub-id><pub-id pub-id-type="pmid">28428369</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vogl</surname><given-names>T</given-names></name><name><surname>Stratis</surname><given-names>A</given-names></name><name><surname>Wixler</surname><given-names>V</given-names></name><name><surname>Völler</surname><given-names>T</given-names></name><name><surname>Thurainayagam</surname><given-names>S</given-names></name><name><surname>Jorch</surname><given-names>SK</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Autoinhibitory regulation of S100A8/S100A9 alarmin activity locally restricts sterile inflammation</article-title><source>The Journal of Clinical Investigation</source><volume>128</volume><fpage>1852</fpage><lpage>1866</lpage><pub-id pub-id-type="doi">10.1172/JCI89867</pub-id><pub-id pub-id-type="pmid">29611822</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walscheid</surname><given-names>K</given-names></name><name><surname>Heiligenhaus</surname><given-names>A</given-names></name><name><surname>Holzinger</surname><given-names>D</given-names></name><name><surname>Roth</surname><given-names>J</given-names></name><name><surname>Heinz</surname><given-names>C</given-names></name><name><surname>Tappeiner</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Elevated S100A8/A9 and S100A12 Serum Levels Reflect Intraocular Inflammation in Juvenile Idiopathic Arthritis-Associated Uveitis: Results From a Pilot Study</article-title><source>Investigative Ophthalmology &amp; Visual Science</source><volume>56</volume><fpage>7653</fpage><lpage>7660</lpage><pub-id pub-id-type="doi">10.1167/iovs.15-17066</pub-id><pub-id pub-id-type="pmid">26624497</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walscheid</surname><given-names>K</given-names></name><name><surname>Weinhage</surname><given-names>T</given-names></name><name><surname>Foell</surname><given-names>D</given-names></name><name><surname>Heinz</surname><given-names>C</given-names></name><name><surname>Kasper</surname><given-names>M</given-names></name><name><surname>Heiligenhaus</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Phenotypic changes of peripheral blood mononuclear cells upon corticosteroid treatment in idiopathic intermediate uveitis</article-title><source>Clinical Immunology</source><volume>28</volume><elocation-id>30534</elocation-id><pub-id pub-id-type="doi">10.1016/j.clim.2016.10.013</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walscheid</surname><given-names>K</given-names></name><name><surname>Neekamp</surname><given-names>L</given-names></name><name><surname>Heiligenhaus</surname><given-names>A</given-names></name><name><surname>Weinhage</surname><given-names>T</given-names></name><name><surname>Holzinger</surname><given-names>D</given-names></name><name><surname>Heinz</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Peripheral blood monocytes reveal an activated phenotype in pediatric uveitis</article-title><source>Clinical Immunology</source><volume>190</volume><fpage>84</fpage><lpage>88</lpage><pub-id pub-id-type="doi">10.1016/j.clim.2017.09.014</pub-id><pub-id pub-id-type="pmid">28923439</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Lu</surname><given-names>R</given-names></name><name><surname>Xu</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>S100A8 promotes migration and infiltration of inflammatory cells in acute anterior uveitis</article-title><source>Scientific Reports</source><volume>6</volume><elocation-id>36140</elocation-id><pub-id pub-id-type="doi">10.1038/srep36140</pub-id><pub-id pub-id-type="pmid">27786310</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wendling</surname><given-names>D</given-names></name><name><surname>Dougados</surname><given-names>M</given-names></name><name><surname>Berenbaum</surname><given-names>F</given-names></name><name><surname>Brocq</surname><given-names>O</given-names></name><name><surname>Schaeverbeke</surname><given-names>T</given-names></name><name><surname>Mazieres</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Rituximab treatment for spondyloarthritis. A nationwide series: data from the AIR registry of the French Society of Rheumatology</article-title><source>The Journal of Rheumatology</source><volume>39</volume><fpage>2327</fpage><lpage>2331</lpage><pub-id pub-id-type="doi">10.3899/jrheum.120201</pub-id><pub-id pub-id-type="pmid">22896028</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wildschütz</surname><given-names>L</given-names></name><name><surname>Ackermann</surname><given-names>D</given-names></name><name><surname>Witten</surname><given-names>A</given-names></name><name><surname>Kasper</surname><given-names>M</given-names></name><name><surname>Busch</surname><given-names>M</given-names></name><name><surname>Glander</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Transcriptomic and proteomic analysis of iris tissue and aqueous humor in juvenile idiopathic arthritis-associated uveitis</article-title><source>Journal of Autoimmunity</source><volume>100</volume><fpage>75</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.1016/j.jaut.2019.03.004</pub-id><pub-id pub-id-type="pmid">30885419</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wolbert</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Heming</surname><given-names>M</given-names></name><name><surname>Mausberg</surname><given-names>AK</given-names></name><name><surname>Akkermann</surname><given-names>D</given-names></name><name><surname>Frydrychowicz</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Redefining the heterogeneity of peripheral nerve cells in health and autoimmunity</article-title><source>PNAS</source><volume>117</volume><fpage>9466</fpage><lpage>9476</lpage><pub-id pub-id-type="doi">10.1073/pnas.1912139117</pub-id><pub-id pub-id-type="pmid">32295886</pub-id></element-citation></ref><ref id="bib87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname><given-names>W</given-names></name><name><surname>Zhou</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Hui</surname><given-names>T</given-names></name><name><surname>Chen</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Wnt/β-catenin signaling plays a key role in the development of spondyloarthritis</article-title><source>Annals of the New York Academy of Sciences</source><volume>1364</volume><fpage>25</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1111/nyas.12968</pub-id><pub-id pub-id-type="pmid">26629686</pub-id></element-citation></ref><ref id="bib88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yin</surname><given-names>X</given-names></name><name><surname>Yu</surname><given-names>H</given-names></name><name><surname>Jin</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Guo</surname><given-names>H</given-names></name><name><surname>Shi</surname><given-names>Q</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Human blood cd1c+ dendritic cells encompass cd5high and cd5low subsets that differ significantly in phenotype, gene expression, and functions</article-title><source>Journal of Immunology</source><volume>198</volume><fpage>1553</fpage><lpage>1564</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1600193</pub-id><pub-id pub-id-type="pmid">28087664</pub-id></element-citation></ref><ref id="bib89"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Q</given-names></name><name><surname>He</surname><given-names>Y</given-names></name><name><surname>Luo</surname><given-names>N</given-names></name><name><surname>Patel</surname><given-names>SJ</given-names></name><name><surname>Han</surname><given-names>Y</given-names></name><name><surname>Gao</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Landscape and dynamics of single immune cells in hepatocellular carcinoma</article-title><source>Cell</source><volume>179</volume><fpage>829</fpage><lpage>845</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2019.10.003</pub-id><pub-id pub-id-type="pmid">31675496</pub-id></element-citation></ref><ref id="bib90"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>B</given-names></name><name><surname>Chen</surname><given-names>W</given-names></name><name><surname>Jiang</surname><given-names>R</given-names></name><name><surname>Zhang</surname><given-names>R</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Expression profile of IL-1 family cytokines in aqueous humor and sera of patients with HLA-B27 associated anterior uveitis and idiopathic anterior uveitis</article-title><source>Experimental Eye Research</source><volume>138</volume><fpage>80</fpage><lpage>86</lpage><pub-id pub-id-type="doi">10.1016/j.exer.2015.06.018</pub-id><pub-id pub-id-type="pmid">26116905</pub-id></element-citation></ref><ref id="bib91"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>GXY</given-names></name><name><surname>Terry</surname><given-names>JM</given-names></name><name><surname>Belgrader</surname><given-names>P</given-names></name><name><surname>Ryvkin</surname><given-names>P</given-names></name><name><surname>Bent</surname><given-names>ZW</given-names></name><name><surname>Wilson</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Massively parallel digital transcriptional profiling of single cells</article-title><source>Nature Communications</source><volume>8</volume><elocation-id>14049</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms14049</pub-id><pub-id pub-id-type="pmid">28091601</pub-id></element-citation></ref><ref id="bib92"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zilionis</surname><given-names>R</given-names></name><name><surname>Engblom</surname><given-names>C</given-names></name><name><surname>Pfirschke</surname><given-names>C</given-names></name><name><surname>Savova</surname><given-names>V</given-names></name><name><surname>Zemmour</surname><given-names>D</given-names></name><name><surname>Saatcioglu</surname><given-names>HD</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Single-Cell Transcriptomics of Human and Mouse Lung Cancers Reveals Conserved Myeloid Populations across Individuals and Species</article-title><source>Immunity</source><volume>50</volume><fpage>1317</fpage><lpage>1334</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2019.03.009</pub-id><pub-id pub-id-type="pmid">30979687</pub-id></element-citation></ref></ref-list></back><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.67396.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>van de Veerdonk</surname><given-names>Frank L</given-names></name><role>Reviewing Editor</role><aff><institution>Radboudumc Center for Infectious Diseases</institution><country>Netherlands</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Rosenbaum</surname><given-names>James T</given-names></name><role>Reviewer</role></contrib></contrib-group></front-stub><body><boxed-text id="box1"><p>Our editorial process produces two outputs: (i) <ext-link ext-link-type="uri" xlink:href="https://sciety.org/articles/activity/10.1101/2021.02.16.431370">public reviews</ext-link> designed to be posted alongside <ext-link ext-link-type="uri" xlink:href="https://www.biorxiv.org/content/10.1101/2021.02.16.431370v1">the preprint</ext-link> for the benefit of readers; (ii) feedback on the manuscript for the authors, including requests for revisions, shown below. We also include an acceptance summary that explains what the editors found interesting or important about the work.</p></boxed-text><p><bold>Acceptance summary:</bold></p><p>This study analyzed intra-ocular cells in subjects with HLA-B27-associated acute anterior uveitis, subjects with HLA-B27-negative anterior uveitis, and bacterial endophthalmitis using several assay techniques including single cell RNA-Seq, fluorescence activated cell sorting, and quantification of multiple cytokines. A unique pattern in HLA-B27 positive uveitis was discovered that exclusively featured plasmacytoid and classical dendritic cells (cDC) infiltrate and plasma cells, which might provide hints for the pathogenesis of this disease.</p><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;Intra-ocular dendritic cells are increased in HLA-B27 associated acute anterior uveitis&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 2 peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Satyajit Rath as the Senior Editor. The following individual involved in review of your submission has agreed to reveal their identity: James T. Rosenbaum (Reviewer #3).</p><p>The reviewers have discussed their reviews with one another, and the Reviewing Editor has drafted this to help you prepare a revised submission.</p><p>Essential revisions:</p><p>Although the study is preliminary the reviewers felt it was novel and contributes to the field.</p><p>• The major strength is the unbiased cell population identification which is the power of single cell sequencing. Despite this strength, the small samples size, variable entities studied, and substantial variability in composition between the samples – which is intrinsic to clinical samples also noted by the authors – makes the impact of the work on the field not entirely certain. Another weakness is that the 'validation' by flow cytometry work is not based on hall mark genes for the clusters identified by scRNAseq and the proportions of cell types identified by scRNAseq and flow cytometry are not comparable. The authors achieved the unbiased characterization of samples of ocular fluid, but did not achieve in linking this information with the cytometry and cytokine data. This should be discussed in the manuscript.</p><p>• In the flow cytometry proportions, the B27 samples contain almost entirely granulocytes while this leukocyte population makes up {plus minus}25% in the scRNAseq data. Also, granulocytes proportions in B27-negative sample 1 and B27-positive sample look similar in scRNA-seq, while in flow cytometry the difference is nearly 6-fold. Although this could understandably be due to inter-assay/platform variability, but this would also point towards the uncertainty in the differences between the groups as a whole. Especially, given the large inter-sample variability in the scRNAseq. This makes the conclusions on group differences not very robust and should be acknowledged in the manuscript.</p><p>• The authors state they use the multiplex assay as a complement to transcriptomics and that this was predefined. However, based on the cell-cell interaction network it would be logical to go for cytokines such as TNFSF13B, TGFB1, CXCL9, but these are missing in the cytokine analysis. Please explain.</p><p>• How does the cytokines serum data on IFNγ and ILRA relate to the other studied data in the eye?</p><p>• It would really help to show the cluster abundance per sample (scatter) to back up the statements on pDC, cDCs, because it is difficult to infer this information from the proportion and pooled ratio (fold change) from figure 2B and C. This will also help the reader to assess how this is affected by inter-patient variability.</p><p>• Perhaps it's easier for readers to adhere to more common nomenclature for dendritic cells subsets, such as cDC1 and cDC2 instead of cDCa/b. or do the author consider these clusters novel populations?</p><p>• Given the large variability in leukocyte composition across the samples and the lack of study of actual peripheral blood samples of these patients, the statement &quot;The relative cluster composition (Figure 1B, Suppl. Tab.4) was considerably different from peripheral blood&quot; is difficult to defend in the result section, perhaps move this to the Discussion section.</p><p>• Similar overstatement: &quot;This suggests that preferential interactions differ between uveitis entities and that the cDCa cluster might be centrally involved in controlling intraocular inflammation in B27+AAU.&quot;. The authors should discuss that cell-cell interaction modelling with few samples and proportionally large variability is subjected to large uncertainty in the accuracy of the proposed interactions.</p><p>• &quot;Low-input proteomics&quot; is a bit overstated for a 25-plex multiplex immunoassay. Even more so since it is both targeted and only focused on cytokines in the pg range.</p><p>• The abstract should ideally include how many subjects were studied by scRNA-Seq.</p><p>• Line 416 indicates that the authors tried to input 5000 cells for RNA-Seq but we learn elsewhere (ln 154) that on average, only 1936 cells were so studied. It seems that about 60% of cells were lost and this could be critical and could be selective. It is unclear if cells were studied fresh or if they had been frozen. The authors need to clarify this discrepancy.</p><p>• The authors state that no topical medications were given at the time of sampling but a supplementary table indicates that several subjects were on topical corticosteroids. Please reconcile.</p><p>• Two subjects were taking adalimumab and that should be mentioned in the body of the paper.</p><p>• Disease duration is given in a supplementary table. However, HLA B27 associated anterior uveitis is episodic. Is disease duration based on the most recent episode (which seems likely to be most relevant) or dated from the first attack of uveitis.</p><p>• The term autoimmune is used multiple times to describe uveitis. B27-associated uveitis is more likely triggered by a foreign antigen. Immune-mediated is a much better term.</p><p>• The introduction states that about 50% of uveitis is anterior. The data from Gritz and Wong or Thorne, Suhler, et al. indicate that the percent is greater than 80.</p><p>• The introduction states that the normal eye does not contain immune system cells. I think that most authorities would disagree. Antigen presenting cells are present in the normal eye and many cells within the eye make cytokines and serve immune functions.</p><p>• I would encourage the authors to be a little more cautious in their conclusions because of the issues discussed in the public review.</p><p>[Editors' note: further revisions were suggested prior to acceptance, as described below.]</p><p>Thank you for resubmitting your work entitled &quot;Intra-ocular dendritic cells characterize HLA-B27-associated acute anterior uveitis&quot; for further consideration by <italic>eLife</italic>. Your revised article has been evaluated by Satyajit Rath as the Senior Editor, and a Reviewing Editor.</p><p>The manuscript has been improved but there are some remaining issues that need to be addressed, as outlined below:</p><p>The manuscript is improved. However, there is one major concern before it can be accepted. The abstract describes studying 6 samples (3 B27+, 2 B27-, one endophthalmitis) but elsewhere in the manuscript and figure legends, it seems that 7 samples including 4 B27 AAU were studied. And sometimes the manuscript says that 11 were studied and four were technical failures. While it is worthwhile to share how often the authors encountered technical problems, it is misleading to say that 11 were studied. Please clarify.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.67396.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>• The major strength is the unbiased cell population identification which is the power of single cell sequencing. Despite this strength, the small samples size, variable entities studied, and substantial variability in composition between the samples – which is intrinsic to clinical samples also noted by the authors – makes the impact of the work on the field not entirely certain. Another weakness is that the 'validation' by flow cytometry work is not based on hall mark genes for the clusters identified by scRNAseq and the proportions of cell types identified by scRNAseq and flow cytometry are not comparable. The authors achieved the unbiased characterization of samples of ocular fluid, but did not achieve in linking this information with the cytometry and cytokine data. This should be discussed in the manuscript.</p></disp-quote><p>We thank the reviewer for this thoughtful feedback. We very much agree that the main advantage of our study is its unbiased approach of precious samples collected from patients with rare diseases. We also concur with the reviewer that the sample size of the patients included is low and that additional validation is advisable. However, due to the invasiveness of the sampling, further recruitment is very difficult. Even at our large uveitis center we achieved a recruitment ratio of 0.18% of all patients. In addition, our ethical approval does not currently cover additional recruitment. We acknowledge and discuss these limitations in a new ‘limitations’ paragraph at the end of the Discussion section on page 15 of the manuscript.</p><disp-quote content-type="editor-comment"><p>• In the flow cytometry proportions, the B27 samples contain almost entirely granulocytes while this leukocyte population makes up {plus minus}25% in the scRNAseq data. Also, granulocytes proportions in B27-negative sample 1 and B27-positive sample look similar in scRNA-seq, while in flow cytometry the difference is nearly 6-fold. Although this could understandably be due to inter-assay/platform variability, but this would also point towards the uncertainty in the differences between the groups as a whole. Especially, given the large inter-sample variability in the scRNAseq. This makes the conclusions on group differences not very robust and should be acknowledged in the manuscript.</p></disp-quote><p>We thank the reviewer for this attentive observation. We now put this into context in the Results section by stating that ´The higher frequency of granulocytes detected in flow cytometry than in the scRNA-seq might be due to higher fragility of these cells during processing for scRNA-seq (Zilionis et al., 2019).´ on page 9 of the manuscript. Following the reviewer’s advice, we now also acknowledge this shortcoming in the new limitation section on page 15 of the manuscript.</p><disp-quote content-type="editor-comment"><p>• The authors state they use the multiplex assay as a complement to transcriptomics and that this was predefined. However, based on the cell-cell interaction network it would be logical to go for cytokines such as TNFSF13B, TGFB1, CXCL9, but these are missing in the cytokine analysis. Please explain.</p></disp-quote><p>We thank the reviewer for this important point. In fact, the text in the result section of the manuscript was previously misleading. In contrast to our previous statement, we did not choose the composition of the proteomics (Luminex) panel based on the observations made in single cell RNA-seq. We therefore first modified the sentence on page 11 of the manuscript: ‘Next, we sought to characterize the intra-ocular immune-response through the analysis of soluble mediators.’</p><p>We initially chose the Luminex kit because we expected it to cover most common cytokines differentiating previously described immune responses in uveitis. We agree with the reviewer that a broader proteomic analysis of these precious samples would have been advisable. We now also acknowledge this point in the new “Limitations of the study” paragraph on page 15 of the manuscript.</p><p>We also wish to explicitly comment on the specific cytokines mentioned by the reviewer in reference to the CellphoneDB analysis. TGF-β can technically not be quantified together with other cytokines in the multiplex array we used, as latent TGF-β has to be preactivated with HCL to the immunoreactive form for quantification. As the bead population of TNFSF13B (BAFF) and CXCL9 procartaplex assay were already covered by beads for other target proteins from the 25xplex Human ProcartaPlex Panel 1B, we could unfortunately not include these cytokines in the analysis. With regard to BAFF, we included a reference where an increased BAFF concentration in AqH of AAU patients during uveitis inactivity was shown (Wildschütz et al., 2019). To also acknowledge this, the following text was included in the Discussion section on page 13: “The cell-to-cell network analysis revealed an involvement of TNFSF13B (BAFF) connecting naive Bc and plasma cells to cDCa. A previous study showed enhanced levels of the B cell factors BAFF and APRIL in AqH of AAU patients during inactive uveitis, pointing to a role of intraocular B cells in AAU (Wildschütz et al., 2019)”.</p><disp-quote content-type="editor-comment"><p>• How does the cytokines serum data on IFNγ and ILRA relate to the other studied data in the eye?</p></disp-quote><p>We thank the reviewer for this relevant point. Unfortunately, we did not include peripheral blood sampling concurrently to the ocular samples. Therefore we analysed available asservated serum samples from other patients during uveitis activity. Thus, a direct linkage to the ocular cytokine pattern in the current study is unfortunately not possible. In future studies, directly comparing cytokine analysis of serum will be performed. We included this shortcoming in a separate paragraph “Limitations of the study”.</p><p>To clarify the different origin of serum samples we used a consecutive numbering of the serum samples (B27- AU 4-8 and B27+AAU 5-10) and added this to Figure 4—figure supplement 2 B.</p><disp-quote content-type="editor-comment"><p>• It would really help to show the cluster abundance per sample (scatter) to back up the statements on pDC, cDCs, because it is difficult to infer this information from the proportion and pooled ratio (fold change) from figure 2B and C. This will also help the reader to assess how this is affected by inter-patient variability.</p></disp-quote><p>We thank the reviewer for this excellent idea. As suggested by the reviewer we included this plot into Figure 2D. This panel now depicts the cluster abundance in each sample grouped by condition (B27-AU vs. B27+AAU).</p><disp-quote content-type="editor-comment"><p>• Perhaps it's easier for readers to adhere to more common nomenclature for dendritic cells subsets, such as cDC1 and cDC2 instead of cDCa/b. or do the author consider these clusters novel populations?</p></disp-quote><p>We thank the reviewer for this important comment. Of course we agree that the nomenclature cDC1 and cDC2 is much more common and is well defined in the field. However, annotating leukocytes (especially from the myeloid lineage) based on single cell transcriptomic data is often challenging and has revealed previously unknown cell populations (or cell states) ((Villani et al., 2017)). In addition, these novel populations do not necessarily match well with protein marker-based annotation. For example, a previous single cell RNA-sequencing study identified 6 types of dendritic cells ((Villani et al., 2017)). While this is one of the key potentials of single cell transcriptomics, it causes considerable ambiguity when interpreting our data.</p><p>The clusters we annotated as classical dendritic cells (cDC) cluster a (cDCa) does express some features of cDC type 1 (cDC1; <italic>CLEC9A, HLA-DPA1</italic>). Similarly, the cDCb cluster partially resembles cDC2 (<italic>BATF3, CLEC10A</italic>).</p><p>However, our clusters cDCa and cDCb do NOT express all the classical cDC1 and cDC2 markers that we (DC1:<italic>CLEC9A, XCR1, BATF3</italic>; DC2: <italic>CD1C, FCER1A, CLEC10A</italic>) (Heming et al., 2021) and others (DC1: <italic>CLEC9A, C1ORF54, HLA-DPA1, CADM1, CAMK2D</italic>; DC2: <italic>CD1C, FCER1A, CLEC10A, ADAM8</italic>) (Villani et al., 2017) identified in other tissues (<xref ref-type="fig" rid="sa2fig1">Author response image 1</xref>) . We also compared our dataset to the DC nomenclature based on single cell transcriptomics, but found no exact overlap between the six transcriptionally defined DC subsets from that study with our cDCa or cDCb clusters (<xref ref-type="fig" rid="sa2fig2">Author response image 2</xref>). We therefore interpreted cautiously and intentionally avoided naming the clusters cDC1 and cDC2 to prevent ambiguity and to not annotate incorrectly.</p><fig id="sa2fig1" position="float"><label>Author response image 1.</label><caption><title>Dot plot of selected marker genes for DC defined in a previous study of Heming et al.</title><p>2020 grouped by cluster. The average gene expression level is color-coded and the circle-size represents the percentage of cells expressing the gene. Threshold was set to a minimum of 10% of cells in the cluster expressing the gene. DC: dendritic cell, pDC: plasmacytoid cell, matDC: mature DC; granulo: granulocytes, NK: natural killer cells, gdTC: γδ T cells, Treg: regulatory T cells, Bc: B cells.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-67396-sa2-fig1-v1.tif"/></fig><fig id="sa2fig2" position="float"><label>Author response image 2.</label><caption><title>UMAP projection of pooled 7 samples (control n=1; B27-AU n=2; B27+AAU n=4).</title><p>The sc transcriptomes were manually annotated to cell types based on marker gene expression of Villani et al.2017, and distinguished in 6 dendritic cell clusters (each dot represents one cell).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-67396-sa2-fig2-v1.tif"/></fig><p>We apologize for this misunderstanding and improved the explanation of the cluster annotations in the text on page 8 of the Results section.</p><p>“The marker genes expressed by the cDC sub-clusters did not fully overlap with previously described cDC type 1/2 markers used to identify DC subsets from cerebrospinal fluid (DC1: CLEC9A, XCR1, BATF3; DC2: CD1C, FCER1A, CLEC10A) (Heming et al., 2021) or peripheral blood (DC1: CLEC9A, C1ORF54, HLA-DPA1, CADM1, CAMK2D; DC2: CD1C, FCER1A, CLEC10A, ADAM8) (Villani et al., 2017). We therefore intentionally named these clusters cDCa/b to prevent ambiguity.”</p><p>We also modified the text on page 14 of the discussion to acknowledge this. If the reviewer disagrees, we will of course modify the cluster naming to cDC1 / cDC2.</p><p>“As the marker genes identified in our study partially differed from cDC1/cDC2 in other tissues (Heming et al., 2021; Villani et al., 2017) we used a distinct annotation as cCDa/cDCb.֧”</p><disp-quote content-type="editor-comment"><p>• Given the large variability in leukocyte composition across the samples and the lack of study of actual peripheral blood samples of these patients, the statement &quot;The relative cluster composition (Figure 1B, Suppl. Tab.4) was considerably different from peripheral blood&quot; is difficult to defend in the result section, perhaps move this to the Discussion section.</p></disp-quote><p>We thank the reviewer for this comment. We have moved this statement to the Discussion section on page 13, and refer to one of the initial scRNA-seq studies characterizing blood (Zheng GXY, Terry JM, Belgrader P, et al. Massively parallel digital transcriptional profiling of single cells. Nat. Commun. 2017;8:14049).</p><disp-quote content-type="editor-comment"><p>• Similar overstatement: &quot;This suggests that preferential interactions differ between uveitis entities and that the cDCa cluster might be centrally involved in controlling intraocular inflammation in B27+AAU.&quot;. The authors should discuss that cell-cell interaction modelling with few samples and proportionally large variability is subjected to large uncertainty in the accuracy of the proposed interactions.</p></disp-quote><p>We agree with the reviewer, that we tended to overinterpret the available data in some sections of the manuscript. Therefore we changed the results text on page 11 accordingly. Furthermore we adapted the text in the Discussion section on page 14 of the manuscript. We have also overall reworked the text to improve its tendency towards overinterpretation.</p><disp-quote content-type="editor-comment"><p>• &quot;Low-input proteomics&quot; is a bit overstated for a 25-plex multiplex immunoassay. Even more so since it is both targeted and only focused on cytokines in the pg range.</p></disp-quote><p>We agree and have changed the term “Low-input proteomic” into “proteomic analysis” throughout the manuscript.</p><disp-quote content-type="editor-comment"><p>• The abstract should ideally include how many subjects were studied by scRNA-Seq.</p></disp-quote><p>We have included this information.</p><disp-quote content-type="editor-comment"><p>• Line 416 indicates that the authors tried to input 5000 cells for RNA-Seq but we learn elsewhere (ln 154) that on average, only 1936 cells were so studied. It seems that about 60% of cells were lost and this could be critical and could be selective. It is unclear if cells were studied fresh or if they had been frozen. The authors need to clarify this discrepancy.</p></disp-quote><p>We thank the reviewer for this comment. We always used freshly isolated cells for the analysis and all cells were processed as quickly as possible. We have also added this information to the Results section on page 7 and to the method section on page 17.</p><p>When performing scRNA-seq using the 10x Chromium single cell controller system, the proportion of cells collected in one droplet and thus falsely interpreted as one cell (i.e. the doublet rate) increases exponentially when &gt;10,000 cells are used as input per run. Given the scarcity of the cells we analyzed this was not much of a concern in the present study. We nevertheless defined 5’000 input cells as our maximum intended input with all excess cells beyond that number used for flow cytometry. This was not to indicate that all samples actually contained that many input cells. In fact, we estimate the mean input to be 1936 cells per sample (see Suppl. File 1b) because the 10x Chromium system generally returns usable data from 50% of the number of input cells (i.e. cell recovery rate is 50%). Our ability to study ~1900 cells is thus in accordance with our expectations.</p><disp-quote content-type="editor-comment"><p>• The authors state that no topical medications were given at the time of sampling but a supplementary table indicates that several subjects were on topical corticosteroids. Please reconcile.</p></disp-quote><p>We clarified this point in the method section and included the following text on page 16 of the manuscript: “Even though patients received topical corticosteroids in previous recurrences, at the time of sampling patients received no topical anti-inflammatory medication.”</p><disp-quote content-type="editor-comment"><p>• Two subjects were taking adalimumab and that should be mentioned in the body of the paper.</p></disp-quote><p>We included the requested information in the result section on page 7 of the manuscript:</p><p>“All B27+AAU patients had associated SpA, two of them received adalimumab therapy. “</p><disp-quote content-type="editor-comment"><p>• Disease duration is given in a supplementary table. However, HLA B27 associated anterior uveitis is episodic. Is disease duration based on the most recent episode (which seems likely to be most relevant) or dated from the first attack of uveitis.</p></disp-quote><p>Disease duration given in the supplementary file 1a is based on the date from the first uveitis episode. We clarified this point in the result section and included the following text on page 7: “….or time since uveitis onset”</p><disp-quote content-type="editor-comment"><p>• The term autoimmune is used multiple times to describe uveitis. B27-associated uveitis is more likely triggered by a foreign antigen. Immune-mediated is a much better term.</p></disp-quote><p>We agree with the reviewer and have therefore changed the term “autoimmune” into “immune-mediated” in the context of B27-associated uveitis throughout the manuscript.</p><disp-quote content-type="editor-comment"><p>• The introduction states that about 50% of uveitis is anterior. The data from Gritz and Wong or Thorne, Suhler, et al. indicate that the percent is greater than 80.</p></disp-quote><p>We have changed the text on page 5 of the manuscript and now cite the following references: Thorne JE, Suhler E, Skup M, et al. Prevalence of Noninfectious Uveitis in the United States: A Claims-Based Analysis. JAMA Ophthalmol. 2016;134(11):1237–1245. doi:10.1001/jamaophthalmol.2016.3229</p><disp-quote content-type="editor-comment"><p>• The introduction states that the normal eye does not contain immune system cells. I think that most authorities would disagree. Antigen presenting cells are present in the normal eye and many cells within the eye make cytokines and serve immune functions.</p></disp-quote><p>We agree, the sentence was set in a wrong context and should be related to the AqH in the anterior chamber which is cell free under non-diseased conditions. We changed the text on page 5 of the manuscript accordingly: “Uveitis describes a heterogeneous group of inflammatory diseases involving uveal tissues in the intraocular cavity of the eye.” We also modified the following sentence on page 5 of the manuscript: “Its typical clinical features include acute onset of discomfort, eye redness, tearing, visual impairment, and excessive cellular infiltration in the aqueous humor (AqH; i.e. the intraocular liquid of the anterior chamber) that is devoid of immune cells under non-diseased conditions.”</p><disp-quote content-type="editor-comment"><p>• I would encourage the authors to be a little more cautious in their conclusions because of the issues discussed in the public review.</p></disp-quote><p>We included a paragraph with limitations of the study and removed the tendency towards overinterpretation from the text.</p><p>The following text was also removed on page 14: “One could thus speculate that uveitis, probably in context with the microenvironment of anterior chamber-associated immune deviation, includes a unique phenotype of regulatory DCs.”</p><p>The following text was also removed on page 15: “The cDCa cluster showed reduced <italic>FOS</italic> expression, mediator of IL-17 signaling (Li et al., 2016), pointing to a subordinated role of Th17 immunity in B27+AAU.”</p><p>References:</p><p>Heming, M., X. Li, S. Räuber, A.K. Mausberg, A.L. Börsch, M. Hartlehnert, A. Singhal, I.N. Lu, M. Fleischer, F. Szepanowski, O. Witzke, T. Brenner, U. Dittmer, N. Yosef, C. Kleinschnitz, H. Wiendl, M. Stettner, and G. Meyer zu Hörste. 2021. Neurological Manifestations of COVID-19 Feature T Cell Exhaustion and Dedifferentiated Monocytes in Cerebrospinal Fluid. Immunity. 54:164–175. doi:10.1016/j.immuni.2020.12.011.</p><p>Li, J., L. Nie, Y. Zhao, Y. Zhang, X. Wang, S. Wang, Y. Liu, H. Zhao, and L. Cheng. 2016. IL-17 mediates inflammatory reactions via p38/c-Fos and <italic>JNK</italic>/c-Jun activation in an AP-1-dependent manner in human nucleus pulposus cells. J. Transl. Med. 14:77. doi:10.1186/s12967-016-0833-9.</p><p>Miyamoto, N., M. Mandai, I. Suzuma, K. Suzuma, K. Kobayashi, and Y. Honda. 1999. Estrogen protects against cellular infiltration by reducing the expressions of E-selectin and IL-6 in endotoxin-induced uveitis. J. Immunol. 163:374–379.</p><p>Peterson, V.M., K.X. Zhang, N. Kumar, J. Wong, L. Li, D.C. Wilson, R. Moore, T.K. McClanahan, S. Sadekova, and J.A. Klappenbach. 2017. Multiplexed quantification of proteins and transcripts in single cells. Nat. Biotechnol. 35:936–939. doi:10.1038/nbt.3973.</p><p>Vieth, B., S. Parekh, C. Ziegenhain, W. Enard, and I. Hellmann. 2019. A systematic evaluation of single cell RNA-seq analysis pipelines. Nat. Commun. 10:4667. doi:10.1038/s41467-019-12266-7.</p><p>Villani, A.-C., R. Satija, G. Reynolds, S. Sarkizova, K. Shekhar, J. Fletcher, M. Griesbeck, A. Butler, S. Zheng, S. Lazo, L. Jardine, D. Dixon, E. Stephenson, E. Nilsson, I. Grundberg, D. McDonald, A. Filby, W. Li, P.L. De Jager, O. Rozenblatt-Rosen, and N. Hacohen. 2017. Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors. Science. 356. doi:10.1126/science.aah4573.</p><p>Wildschütz, L., D. Ackermann, A. Witten, M. Kasper, M. Busch, S. Glander, H. Melkonyan, K. Walscheid, C. Tappeiner, S. Thanos, A. Barysenka, J. Koch, C. Heinz, B. Laffer, D. Bauer, M. Stoll, S. König, and A. Heiligenhaus. 2019. Transcriptomic and proteomic analysis of iris tissue and aqueous humor in juvenile idiopathic arthritis-associated uveitis. J. Autoimmun. 100:75–83. doi:10.1016/j.jaut.2019.03.004.</p><p>Zilionis, R., C. Engblom, C. Pfirschke, V. Savova, D. Zemmour, H.D. Saatcioglu, I. Krishnan, G. Maroni, C.V. Meyerovitz, C.M. Kerwin, S. Choi, W.G. Richards, A. De Rienzo, D.G. Tenen, R. Bueno, E. Levantini, M.J. Pittet, and A.M. Klein. 2019. Single-Cell Transcriptomics of Human and Mouse Lung Cancers Reveals Conserved Myeloid Populations across Individuals and Species. Immunity. 50:1317-1334.e10. doi:10.1016/j.immuni.2019.03.009.</p><p>[Editors' note: further revisions were suggested prior to acceptance, as described below.]</p><disp-quote content-type="editor-comment"><p>The manuscript has been improved but there are some remaining issues that need to be addressed, as outlined below:</p><p>The manuscript is improved. However, there is one major concern before it can be accepted. The abstract describes studying 6 samples (3 B27+, 2 B27-, one endophthalmitis) but elsewhere in the manuscript and figure legends, it seems that 7 samples including 4 B27 AAU were studied. And sometimes the manuscript says that 11 were studied and four were technical failures. While it is worthwhile to share how often the authors encountered technical problems, it is misleading to say that 11 were studied. Please clarify.</p></disp-quote><p>We thank the editor for this attentive observation. We agree, the description of the study design previously became confusing.</p><p>We summarized each individual experimental analysis in Suppl. File 1a. In total 11 AqH samples were collected. In 10 out of 11 samples cytokine analysis was performed. In seven out of 11 samples scRNA Seq analysis were performed. Five out of seven scRNA-Seq samples underwent parallel flow cytometric analysis.</p><p>We clarified this point in the abstract and in the Results section:</p><p>“…HLA-B27 positive (n=4) …”</p><p>“In 10 of the AqH samples cytokine analysis was performed. Cellular infiltrate were analysed via scRNA-Seq in AqH samples of four patients with active B27+AAU, two patients with active B27-AU, and one patient with active bacterial endophthalmitis (Streptococcus pneumoniae), five of those samples were analysed in parallel via flow cytometry (Suppl. File 1a).”</p></body></sub-article></article>